,pathway_count,genes_related
IMMUNE SYSTEM,86,"['TGFB1', 'CAMP', 'ELANE', 'TNFRSF1A', 'SLPI', 'TNF', 'DCTN4', 'MUC5B', 'IL1B', 'CXCR1', 'CXCL8', 'TLR4', 'TLR5', 'CCL2', 'CAT', 'BPI', 'IFNA1', 'DEFB1', 'DEFB4A', 'CXCR2', 'HP', 'GSN', 'CD8A', 'SERPINA1', 'MUC4', 'AKT1', 'MUC5AC', 'CTSG', 'TIMP1', 'MPO', 'IL2', 'IL4', 'IL5', 'PRTN3', 'TTR', 'PI3', 'C3', 'BPIFB1', 'CRP', 'LPO', 'EGFR', 'LY96', 'NOD2', 'F2', 'NOS2', 'SMAD3', 'NLRP3', 'IL6', 'VEGFA', 'TP53', 'MAPK1', 'CD4', 'FOS', 'SOD1', 'POMC', 'MMP9', 'MAPK8', 'CDKN1A', 'RELA', 'PTGS2', 'STAT3', 'IL10', 'CISH', 'MUC7', 'MMP2', 'PIK3CA', 'MAPK3', 'GPI', 'CASP3', 'BCL2', 'MTOR', 'EGF', 'CCND1', 'ITGAM', 'CD40', 'CD44', 'PSMB6', 'CTLA4', 'CREBBP', 'SOD2', 'IFNG', 'APOB', 'CRK', 'KIT', 'HIF1A', 'PTEN']"
SIGNAL TRANSDUCTION,61,"['CFTR', 'TGFB1', 'TNFRSF1A', 'TNF', 'CXCR1', 'CXCL8', 'LEP', 'INS', 'FAS', 'CCL2', 'PTH', 'CXCR2', 'VIP', 'AKT1', 'SCT', 'IL2', 'IL5', 'NR3C1', 'TTR', 'C3', 'FAM13A', 'EGFR', 'PPARG', 'F2', 'P2RY2', 'SMAD3', 'IL6', 'VEGFA', 'TP53', 'MAPK1', 'FOS', 'POMC', 'MMP9', 'AR', 'MAPK8', 'CDKN1A', 'ESR1', 'RELA', 'BAX', 'STAT3', 'MMP2', 'PIK3CA', 'MAPK3', 'CASP3', 'BCL2', 'MTOR', 'RHO', 'EGF', 'CCND1', 'HGS', 'SST', 'CCK', 'GRK2', 'PSMB6', 'CREBBP', 'PGR', 'APOB', 'CRK', 'KIT', 'HIF1A', 'PTEN']"
DISEASE,52,"['CFTR', 'TGFB1', 'MUC5B', 'IL1B', 'TLR4', 'TLR5', 'PTH', 'SLC26A3', 'VIP', 'MUC4', 'AKT1', 'MUC5AC', 'SCT', 'CTSG', 'NR3C1', 'TTR', 'C3', 'GUCY2C', 'SLC26A4', 'EGFR', 'LY96', 'ABCC8', 'F2', 'NOS2', 'SMAD3', 'NLRP3', 'IL6', 'VEGFA', 'MAPK1', 'CD4', 'POMC', 'MAPK8', 'CDKN1A', 'ESR1', 'RELA', 'STAT3', 'IL10', 'MUC7', 'PIK3CA', 'MAPK3', 'CP', 'MTOR', 'EGF', 'CCND1', 'HGS', 'PSMB6', 'CREBBP', 'SLC17A5', 'SOD2', 'CRK', 'KIT', 'PTEN']"
CYTOKINE SIGNALING IN IMMUNE SYSTEM,50,"['TGFB1', 'TNFRSF1A', 'TNF', 'IL1B', 'CXCL8', 'CCL2', 'IFNA1', 'AKT1', 'CTSG', 'TIMP1', 'IL2', 'IL4', 'IL5', 'PRTN3', 'EGFR', 'NOD2', 'NOS2', 'SMAD3', 'IL6', 'VEGFA', 'TP53', 'MAPK1', 'CD4', 'FOS', 'SOD1', 'POMC', 'MMP9', 'MAPK8', 'CDKN1A', 'RELA', 'PTGS2', 'STAT3', 'IL10', 'CISH', 'MMP2', 'PIK3CA', 'MAPK3', 'CASP3', 'BCL2', 'EGF', 'CCND1', 'ITGAM', 'CD40', 'CD44', 'PSMB6', 'SOD2', 'IFNG', 'CRK', 'KIT', 'HIF1A']"
INNATE IMMUNE SYSTEM,50,"['CAMP', 'ELANE', 'SLPI', 'MUC5B', 'IL1B', 'CXCR1', 'TLR4', 'TLR5', 'CAT', 'BPI', 'IFNA1', 'DEFB1', 'DEFB4A', 'CXCR2', 'HP', 'GSN', 'SERPINA1', 'MUC4', 'MUC5AC', 'CTSG', 'MPO', 'PRTN3', 'TTR', 'PI3', 'C3', 'BPIFB1', 'CRP', 'LPO', 'LY96', 'NOD2', 'F2', 'NOS2', 'NLRP3', 'MAPK1', 'CD4', 'FOS', 'MMP9', 'MAPK8', 'RELA', 'MUC7', 'PIK3CA', 'MAPK3', 'GPI', 'BCL2', 'ITGAM', 'CD44', 'PSMB6', 'CREBBP', 'APOB', 'CRK']"
METABOLISM OF PROTEINS,47,"['CFTR', 'TGFB1', 'DCTN4', 'MUC5B', 'CXCL8', 'LEP', 'INS', 'CCL2', 'GSN', 'SERPINA1', 'MUC4', 'MUC5AC', 'CTSG', 'TIMP1', 'NR3C1', 'TTR', 'C3', 'REN', 'PPARG', 'ALB', 'NOD2', 'F2', 'P2RY2', 'SMAD3', 'NLRP3', 'IL6', 'TP53', 'POMC', 'AR', 'ESR1', 'RELA', 'STAT3', 'WDTC1', 'CISH', 'MUC7', 'MMP2', 'CP', 'PPARA', 'HGS', 'PSMB6', 'CREBBP', 'SLC17A5', 'PGR', 'APOB', 'HIF1A', 'ACE', 'PTEN']"
SIGNALING BY INTERLEUKINS,44,"['TGFB1', 'TNFRSF1A', 'TNF', 'IL1B', 'CXCL8', 'CCL2', 'AKT1', 'CTSG', 'TIMP1', 'IL2', 'IL4', 'IL5', 'PRTN3', 'NOD2', 'NOS2', 'SMAD3', 'IL6', 'VEGFA', 'TP53', 'MAPK1', 'CD4', 'FOS', 'SOD1', 'POMC', 'MMP9', 'MAPK8', 'CDKN1A', 'RELA', 'PTGS2', 'STAT3', 'IL10', 'CISH', 'MMP2', 'PIK3CA', 'MAPK3', 'CASP3', 'BCL2', 'CCND1', 'ITGAM', 'PSMB6', 'SOD2', 'IFNG', 'CRK', 'HIF1A']"
GENERIC TRANSCRIPTION PATHWAY,37,"['TGFB1', 'INS', 'FAS', 'CAT', 'AKT1', 'IL2', 'NR3C1', 'EGFR', 'PPARG', 'SMAD3', 'IL6', 'VEGFA', 'TP53', 'MAPK1', 'FOS', 'POMC', 'AR', 'CDKN1A', 'ESR1', 'RELA', 'BAX', 'MAPK3', 'GPI', 'MTOR', 'CCND1', 'PPARA', 'G6PD', 'SST', 'GSR', 'PSMB6', 'CTLA4', 'CREBBP', 'SOD2', 'IFNG', 'PGR', 'KIT', 'PTEN']"
RNA POLYMERASE II TRANSCRIPTION,37,"['TGFB1', 'INS', 'FAS', 'CAT', 'AKT1', 'IL2', 'NR3C1', 'EGFR', 'PPARG', 'SMAD3', 'IL6', 'VEGFA', 'TP53', 'MAPK1', 'FOS', 'POMC', 'AR', 'CDKN1A', 'ESR1', 'RELA', 'BAX', 'MAPK3', 'GPI', 'MTOR', 'CCND1', 'PPARA', 'G6PD', 'SST', 'GSR', 'PSMB6', 'CTLA4', 'CREBBP', 'SOD2', 'IFNG', 'PGR', 'KIT', 'PTEN']"
GENE EXPRESSION (TRANSCRIPTION),37,"['TGFB1', 'INS', 'FAS', 'CAT', 'AKT1', 'IL2', 'NR3C1', 'EGFR', 'PPARG', 'SMAD3', 'IL6', 'VEGFA', 'TP53', 'MAPK1', 'FOS', 'POMC', 'AR', 'CDKN1A', 'ESR1', 'RELA', 'BAX', 'MAPK3', 'GPI', 'MTOR', 'CCND1', 'PPARA', 'G6PD', 'SST', 'GSR', 'PSMB6', 'CTLA4', 'CREBBP', 'SOD2', 'IFNG', 'PGR', 'KIT', 'PTEN']"
POST-TRANSLATIONAL PROTEIN MODIFICATION,35,"['CFTR', 'TGFB1', 'DCTN4', 'MUC5B', 'INS', 'SERPINA1', 'MUC4', 'MUC5AC', 'TIMP1', 'NR3C1', 'C3', 'PPARG', 'ALB', 'NOD2', 'F2', 'SMAD3', 'NLRP3', 'IL6', 'TP53', 'AR', 'ESR1', 'RELA', 'WDTC1', 'CISH', 'MUC7', 'CP', 'PPARA', 'HGS', 'PSMB6', 'CREBBP', 'SLC17A5', 'PGR', 'APOB', 'HIF1A', 'PTEN']"
METABOLISM,27,"['CA2', 'INS', 'AKT1', 'TTR', 'PPARG', 'ALB', 'ABCC8', 'PRSS1', 'TH', 'POMC', 'PTGS2', 'CYP3A4', 'PIK3CA', 'PTS', 'GPI', 'PPARA', 'G6PD', 'ABCB1', 'AHR', 'GSR', 'CD44', 'GC', 'PSMB6', 'CREBBP', 'APOB', 'CYP2E1', 'PTEN']"
INFECTIOUS DISEASE,24,"['TGFB1', 'IL1B', 'PTH', 'VIP', 'SCT', 'CTSG', 'NR3C1', 'C3', 'GUCY2C', 'EGFR', 'NOS2', 'NLRP3', 'IL6', 'VEGFA', 'MAPK1', 'CD4', 'POMC', 'MAPK8', 'RELA', 'IL10', 'MAPK3', 'HGS', 'PSMB6', 'CRK']"
INTERLEUKIN-4 AND INTERLEUKIN-13 SIGNALING,24,"['TGFB1', 'TNF', 'IL1B', 'CXCL8', 'CCL2', 'AKT1', 'TIMP1', 'IL4', 'NOS2', 'IL6', 'VEGFA', 'TP53', 'FOS', 'POMC', 'MMP9', 'CDKN1A', 'PTGS2', 'STAT3', 'IL10', 'MMP2', 'BCL2', 'CCND1', 'ITGAM', 'HIF1A']"
CELLULAR RESPONSES TO STRESS,24,"['DCTN4', 'CXCL8', 'CAT', 'NR3C1', 'HSPA4', 'IL6', 'VEGFA', 'TP53', 'MAPK1', 'FOS', 'SOD1', 'AR', 'MAPK8', 'CDKN1A', 'RELA', 'STAT3', 'MAPK3', 'MTOR', 'GSR', 'PSMB6', 'CREBBP', 'SOD2', 'PGR', 'HIF1A']"
CELLULAR RESPONSES TO EXTERNAL STIMULI,24,"['DCTN4', 'CXCL8', 'CAT', 'NR3C1', 'HSPA4', 'IL6', 'VEGFA', 'TP53', 'MAPK1', 'FOS', 'SOD1', 'AR', 'MAPK8', 'CDKN1A', 'RELA', 'STAT3', 'MAPK3', 'MTOR', 'GSR', 'PSMB6', 'CREBBP', 'SOD2', 'PGR', 'HIF1A']"
TRANSPORT OF SMALL MOLECULES,22,"['CFTR', 'SCNN1B', 'CLCA1', 'SCNN1G', 'CA2', 'ANO1', 'SCNN1A', 'SLC26A9', 'SLC26A3', 'HFE', 'AQP2', 'ATP12A', 'SLC12A2', 'SLC26A4', 'AQP5', 'ALB', 'MCOLN1', 'CP', 'ABCB1', 'PSMB6', 'SLC17A5', 'APOB']"
SIGNALING BY GPCR,22,"['CXCR1', 'CXCL8', 'CCL2', 'PTH', 'CXCR2', 'VIP', 'AKT1', 'SCT', 'TTR', 'C3', 'EGFR', 'F2', 'P2RY2', 'MAPK1', 'POMC', 'PIK3CA', 'MAPK3', 'RHO', 'SST', 'CCK', 'GRK2', 'APOB']"
HEMOSTASIS,21,"['TGFB1', 'IFNA1', 'SERPINA1', 'AKT1', 'TIMP1', 'PRTN3', 'ALB', 'ANXA5', 'F2', 'NOS2', 'VEGFA', 'TP53', 'MAPK1', 'SOD1', 'PIK3CA', 'MAPK3', 'EGF', 'ITGAM', 'CD44', 'APOB', 'CRK']"
DEVELOPMENTAL BIOLOGY,21,"['TGFB1', 'TNF', 'LEP', 'INS', 'AKT1', 'PI3', 'EGFR', 'PPARG', 'SMAD3', 'MAPK1', 'MMP9', 'MAPK8', 'CDKN1A', 'RELA', 'STAT3', 'MMP2', 'PIK3CA', 'MAPK3', 'PPARA', 'PSMB6', 'CREBBP']"
SPINAL CORD INJURY,21,"['TGFB1', 'TNF', 'IL1B', 'CXCL8', 'LEP', 'TLR4', 'CCL2', 'IL2', 'IL4', 'EGFR', 'NOS2', 'IL6', 'TP53', 'MAPK1', 'FOS', 'MMP9', 'PTGS2', 'MAPK3', 'CASP3', 'CCND1', 'IFNG']"
NUCLEAR RECEPTORS META-PATHWAY,21,"['TGFB1', 'TNF', 'IL1B', 'SCNN1A', 'CCL2', 'SERPINA1', 'IL2', 'NR3C1', 'EGFR', 'ESR1', 'PTGS2', 'BAX', 'STAT3', 'CYP3A4', 'CCND1', 'PPARA', 'G6PD', 'ABCB1', 'AHR', 'GSR', 'IFNG']"
GPCR DOWNSTREAM SIGNALLING,21,"['CXCR1', 'CXCL8', 'PTH', 'CXCR2', 'VIP', 'AKT1', 'SCT', 'TTR', 'C3', 'EGFR', 'F2', 'P2RY2', 'MAPK1', 'POMC', 'PIK3CA', 'MAPK3', 'RHO', 'SST', 'CCK', 'GRK2', 'APOB']"
PI3K-AKT SIGNALING PATHWAY,21,"['TLR4', 'INS', 'IFNA1', 'AKT1', 'IL2', 'IL4', 'EGFR', 'IL6', 'VEGFA', 'TP53', 'MAPK1', 'CDKN1A', 'RELA', 'PIK3CA', 'MAPK3', 'BCL2', 'MTOR', 'EGF', 'CCND1', 'KIT', 'PTEN']"
NEUTROPHIL DEGRANULATION,20,"['CAMP', 'ELANE', 'SLPI', 'CXCR1', 'CAT', 'BPI', 'CXCR2', 'HP', 'GSN', 'SERPINA1', 'CTSG', 'MPO', 'PRTN3', 'TTR', 'C3', 'MAPK1', 'MMP9', 'GPI', 'ITGAM', 'CD44']"
VEGFA-VEGFR2 SIGNALING PATHWAY,19,"['CXCL8', 'FAS', 'CCL2', 'AKT1', 'VEGFA', 'MAPK1', 'MAPK8', 'RELA', 'PTGS2', 'STAT3', 'MMP2', 'PIK3CA', 'MAPK3', 'BCL2', 'MTOR', 'CCND1', 'HGS', 'SOD2', 'CRK']"
HEPATITIS C AND HEPATOCELLULAR CARCINOMA,18,"['TGFB1', 'CXCR1', 'CXCL8', 'AKT1', 'NOS2', 'SMAD3', 'IL6', 'VEGFA', 'TP53', 'MAPK8', 'CDKN1A', 'PTGS2', 'STAT3', 'MAPK3', 'CASP3', 'CCND1', 'CD44', 'HIF1A']"
NONALCOHOLIC FATTY LIVER DISEASE,18,"['TGFB1', 'TNFRSF1A', 'TNF', 'IL1B', 'CXCL8', 'LEP', 'INS', 'FAS', 'CCL2', 'AKT1', 'IL6', 'MAPK8', 'RELA', 'BAX', 'PIK3CA', 'CASP3', 'PPARA', 'CYP2E1']"
FOLATE METABOLISM,18,"['TNF', 'IL1B', 'INS', 'CCL2', 'CAT', 'MPO', 'IL2', 'IL4', 'CRP', 'ALB', 'F2', 'IL6', 'TP53', 'SOD1', 'RELA', 'SOD2', 'IFNG', 'APOB']"
SIGNALING BY RECEPTOR TYROSINE KINASES,18,"['INS', 'AKT1', 'EGFR', 'VEGFA', 'MAPK1', 'FOS', 'MMP9', 'ESR1', 'BAX', 'STAT3', 'PIK3CA', 'MAPK3', 'MTOR', 'EGF', 'HGS', 'PGR', 'CRK', 'KIT']"
PANCREATIC ADENOCARCINOMA PATHWAY,17,"['TGFB1', 'AKT1', 'EGFR', 'SMAD3', 'VEGFA', 'TP53', 'MAPK1', 'MAPK8', 'CDKN1A', 'RELA', 'BAX', 'STAT3', 'PIK3CA', 'MAPK3', 'MTOR', 'EGF', 'CCND1']"
VIRAL ACUTE MYOCARDITIS,17,"['TGFB1', 'TNF', 'TLR4', 'TLR5', 'AKT1', 'IL6', 'MAPK1', 'CD4', 'MMP9', 'BAX', 'STAT3', 'IL10', 'MAPK3', 'CASP3', 'BCL2', 'CCND1', 'IFNG']"
APOPTOSIS,17,"['TNFRSF1A', 'TNF', 'TLR4', 'FAS', 'GSN', 'AKT1', 'LY96', 'TP53', 'MAPK1', 'MAPK8', 'RELA', 'BAX', 'STAT3', 'MAPK3', 'CASP3', 'BCL2', 'PSMB6']"
REGULATION OF TOLL-LIKE RECEPTOR SIGNALING PATHWAY,17,"['TNF', 'IL1B', 'CXCL8', 'TLR4', 'TLR5', 'IFNA1', 'AKT1', 'LY96', 'IL6', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'CISH', 'PIK3CA', 'MAPK3', 'CD40']"
SELENIUM MICRONUTRIENT NETWORK,17,"['TNF', 'IL1B', 'INS', 'CCL2', 'CAT', 'MPO', 'CRP', 'ALB', 'F2', 'IL6', 'SOD1', 'RELA', 'PTGS2', 'GSR', 'SOD2', 'IFNG', 'APOB']"
DISEASES OF SIGNAL TRANSDUCTION,16,"['TGFB1', 'AKT1', 'EGFR', 'SMAD3', 'MAPK1', 'CDKN1A', 'ESR1', 'STAT3', 'PIK3CA', 'MAPK3', 'MTOR', 'EGF', 'PSMB6', 'CREBBP', 'KIT', 'PTEN']"
ALLOGRAFT REJECTION,16,"['TGFB1', 'TNF', 'IL1B', 'CXCL8', 'FAS', 'IL2', 'IL4', 'IL5', 'C3', 'VEGFA', 'IL10', 'CASP3', 'ABCB1', 'CD40', 'CTLA4', 'IFNG']"
MAPK SIGNALING PATHWAY,16,"['TGFB1', 'TNFRSF1A', 'TNF', 'IL1B', 'FAS', 'AKT1', 'EGFR', 'TP53', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3', 'CASP3', 'EGF', 'CRK']"
TOLL-LIKE RECEPTOR SIGNALING PATHWAY,16,"['TNF', 'IL1B', 'CXCL8', 'TLR4', 'TLR5', 'IFNA1', 'AKT1', 'LY96', 'IL6', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'PIK3CA', 'MAPK3', 'CD40']"
JAK-STAT,16,"['IL1B', 'AKT1', 'TIMP1', 'EGFR', 'MAPK1', 'FOS', 'MAPK8', 'ESR1', 'BAX', 'STAT3', 'CISH', 'PIK3CA', 'MAPK3', 'MTOR', 'EGF', 'CCND1']"
INTRACELLULAR SIGNALING BY SECOND MESSENGERS,16,"['INS', 'AKT1', 'EGFR', 'PPARG', 'TP53', 'MAPK1', 'CDKN1A', 'ESR1', 'PIK3CA', 'MAPK3', 'MTOR', 'EGF', 'GRK2', 'PSMB6', 'KIT', 'PTEN']"
BREAST CANCER PATHWAY,16,"['AKT1', 'EGFR', 'TP53', 'MAPK1', 'FOS', 'CDKN1A', 'ESR1', 'BAX', 'PIK3CA', 'MAPK3', 'MTOR', 'EGF', 'CCND1', 'PGR', 'KIT', 'PTEN']"
LUNG FIBROSIS,15,"['TGFB1', 'TNF', 'MUC5B', 'IL1B', 'CXCL8', 'CCL2', 'SERPINA1', 'TIMP1', 'IL4', 'IL5', 'FAM13A', 'IL6', 'MMP9', 'MMP2', 'EGF']"
SENESCENCE AND AUTOPHAGY IN CANCER,15,"['TGFB1', 'IL1B', 'CXCL8', 'INS', 'GSN', 'SMAD3', 'IL6', 'TP53', 'MAPK1', 'CDKN1A', 'BCL2', 'MTOR', 'CD44', 'IFNG', 'PTEN']"
PHOTODYNAMIC THERAPY-INDUCED AP-1 SURVIVAL SIGNALING.,15,"['TNFRSF1A', 'TNF', 'FAS', 'IL2', 'EGFR', 'IL6', 'TP53', 'FOS', 'MAPK8', 'CDKN1A', 'BAX', 'MMP2', 'BCL2', 'CCND1', 'IFNG']"
R-HSA-9658195,15,"['IL1B', 'PTH', 'VIP', 'SCT', 'CTSG', 'C3', 'NLRP3', 'IL6', 'MAPK1', 'POMC', 'MAPK8', 'RELA', 'IL10', 'MAPK3', 'CRK']"
PIP3 ACTIVATES AKT SIGNALING,15,"['INS', 'AKT1', 'EGFR', 'PPARG', 'TP53', 'MAPK1', 'CDKN1A', 'ESR1', 'PIK3CA', 'MAPK3', 'MTOR', 'EGF', 'PSMB6', 'KIT', 'PTEN']"
AGE-RAGE PATHWAY,15,"['INS', 'AKT1', 'EGFR', 'NOS2', 'SMAD3', 'MAPK1', 'SOD1', 'MMP9', 'MAPK8', 'RELA', 'STAT3', 'MMP2', 'MAPK3', 'CASP3', 'HIF1A']"
FOCAL ADHESION-PI3K-AKT-MTOR-SIGNALING PATHWAY,15,"['INS', 'AKT1', 'IL2', 'EGFR', 'NOS2', 'VEGFA', 'MAPK1', 'CDKN1A', 'PIK3CA', 'MAPK3', 'MTOR', 'EGF', 'KIT', 'HIF1A', 'PTEN']"
"PLATELET ACTIVATION, SIGNALING AND AGGREGATION",14,"['TGFB1', 'SERPINA1', 'AKT1', 'TIMP1', 'ALB', 'ANXA5', 'F2', 'VEGFA', 'MAPK1', 'SOD1', 'PIK3CA', 'MAPK3', 'EGF', 'CRK']"
ADIPOGENESIS,14,"['TGFB1', 'TNF', 'LEP', 'INS', 'FAS', 'NR3C1', 'PPARG', 'SMAD3', 'IL6', 'CDKN1A', 'STAT3', 'PPARA', 'AHR', 'HIF1A']"
CHROMOSOMAL AND MICROSATELLITE INSTABILITY IN COLORECTAL CANCER,14,"['TGFB1', 'AKT1', 'SMAD3', 'TP53', 'MAPK1', 'FOS', 'MAPK8', 'CDKN1A', 'PTGS2', 'BAX', 'MAPK3', 'CASP3', 'BCL2', 'CCND1']"
DNA DAMAGE RESPONSE (ONLY ATM DEPENDENT),14,"['TGFB1', 'CAT', 'AKT1', 'SMAD3', 'TP53', 'MAPK1', 'MAPK8', 'CDKN1A', 'BAX', 'PIK3CA', 'BCL2', 'CCND1', 'SOD2', 'PTEN']"
VITAMIN B12 METABOLISM,14,"['TNF', 'IL1B', 'INS', 'CCL2', 'MPO', 'CRP', 'ALB', 'F2', 'IL6', 'SOD1', 'RELA', 'SOD2', 'IFNG', 'APOB']"
T-CELL ANTIGEN RECEPTOR (TCR) PATHWAY DURING STAPHYLOCOCCUS AUREUS INFECTION,14,"['TNF', 'CD8A', 'AKT1', 'AHSA1', 'IL2', 'IL4', 'IL5', 'CD4', 'FOS', 'IL10', 'PIK3CA', 'MAPK3', 'CTLA4', 'IFNG']"
ADAPTIVE IMMUNE SYSTEM,14,"['DCTN4', 'TLR4', 'CD8A', 'AKT1', 'C3', 'LY96', 'CD4', 'RELA', 'PIK3CA', 'MTOR', 'CD40', 'PSMB6', 'CTLA4', 'PTEN']"
LEPTIN SIGNALING PATHWAY,14,"['IL1B', 'LEP', 'AKT1', 'MAPK1', 'MAPK8', 'ESR1', 'RELA', 'BAX', 'STAT3', 'CISH', 'MAPK3', 'MTOR', 'CCND1', 'PTEN']"
GPCR LIGAND BINDING,14,"['CXCR1', 'CXCL8', 'CCL2', 'PTH', 'CXCR2', 'VIP', 'SCT', 'C3', 'F2', 'P2RY2', 'POMC', 'RHO', 'SST', 'CCK']"
PROGRAMMED CELL DEATH,14,"['TLR4', 'FAS', 'GSN', 'AKT1', 'LY96', 'TP53', 'MAPK1', 'MAPK8', 'BAX', 'STAT3', 'MAPK3', 'CASP3', 'BCL2', 'PSMB6']"
ESR-MEDIATED SIGNALING,14,"['AKT1', 'EGFR', 'MAPK1', 'FOS', 'MMP9', 'ESR1', 'MMP2', 'PIK3CA', 'MAPK3', 'BCL2', 'EGF', 'CCND1', 'CREBBP', 'PGR']"
SIGNALING BY NUCLEAR RECEPTORS,14,"['AKT1', 'EGFR', 'MAPK1', 'FOS', 'MMP9', 'ESR1', 'MMP2', 'PIK3CA', 'MAPK3', 'BCL2', 'EGF', 'CCND1', 'CREBBP', 'PGR']"
VESICLE-MEDIATED TRANSPORT,13,"['CFTR', 'DCTN4', 'INS', 'HP', 'SERPINA1', 'AKT1', 'EGFR', 'ALB', 'CD4', 'EGF', 'HGS', 'GRK2', 'APOB']"
CORTICOTROPIN-RELEASING HORMONE SIGNALING PATHWAY,13,"['TGFB1', 'CXCL8', 'TLR4', 'AKT1', 'IL2', 'MAPK1', 'FOS', 'POMC', 'MAPK8', 'RELA', 'MAPK3', 'CASP3', 'BCL2']"
VITAMIN D RECEPTOR PATHWAY,13,"['TGFB1', 'CAMP', 'PTH', 'DEFB4A', 'CDKN1A', 'CYP3A4', 'CCND1', 'G6PD', 'ABCB1', 'ITGAM', 'CD40', 'CTLA4', 'HIF1A']"
PROTEIN ALKYLATION LEADING TO LIVER FIBROSIS,13,"['TGFB1', 'TNF', 'CCL2', 'TIMP1', 'PPARG', 'SMAD3', 'IL6', 'MAPK1', 'MAPK8', 'BAX', 'MMP2', 'MAPK3', 'IFNG']"
T-CELL ANTIGEN RECEPTOR (TCR) SIGNALING PATHWAY,13,"['TGFB1', 'IL1B', 'FAS', 'CD8A', 'AKT1', 'IL6', 'MAPK1', 'CD4', 'FOS', 'MAPK8', 'RELA', 'MAPK3', 'CRK']"
"NON-GENOMIC ACTIONS OF 1,25 DIHYDROXYVITAMIN D3",13,"['CAMP', 'TNFRSF1A', 'TNF', 'CXCL8', 'TLR4', 'CCL2', 'DEFB4A', 'NOD2', 'IL6', 'MAPK1', 'MAPK8', 'MAPK3', 'CD40']"
SUDDEN INFANT DEATH SYNDROME (SIDS) SUSCEPTIBILITY PATHWAYS,13,"['TNF', 'IL1B', 'CXCL8', 'NR3C1', 'IL6', 'VEGFA', 'TH', 'AR', 'IL10', 'CASP3', 'SST', 'CREBBP', 'HIF1A']"
ONCOSTATIN M SIGNALING PATHWAY,13,"['CCL2', 'AKT1', 'VEGFA', 'TP53', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'STAT3', 'MAPK3', 'CASP3', 'MTOR', 'HIF1A']"
PROLACTIN SIGNALING PATHWAY,13,"['AKT1', 'NOS2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'STAT3', 'CISH', 'PIK3CA', 'MAPK3', 'CASP3', 'MTOR', 'PPIB']"
RAC1-PAK1-P38-MMP2 PATHWAY,13,"['AKT1', 'EGFR', 'NOS2', 'TP53', 'MAPK1', 'MAPK8', 'RELA', 'BAX', 'STAT3', 'MMP2', 'PIK3CA', 'MAPK3', 'CRK']"
DEUBIQUITINATION,12,"['CFTR', 'TGFB1', 'NOD2', 'SMAD3', 'NLRP3', 'TP53', 'AR', 'ESR1', 'HGS', 'PSMB6', 'HIF1A', 'PTEN']"
EXTRACELLULAR MATRIX ORGANIZATION,12,"['TGFB1', 'ELANE', 'CTSG', 'TIMP1', 'TTR', 'PRSS1', 'MMP9', 'MMP2', 'CASP3', 'ITGAM', 'CD44', 'PPIB']"
PHOTODYNAMIC THERAPY-INDUCED NF-KB SURVIVAL SIGNALING,12,"['TNFRSF1A', 'TNF', 'IL1B', 'CXCL8', 'IL2', 'IL6', 'VEGFA', 'MMP9', 'RELA', 'PTGS2', 'MMP2', 'CCND1']"
TOLL-LIKE RECEPTOR CASCADES,12,"['TLR4', 'TLR5', 'BPI', 'LY96', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3', 'ITGAM', 'APOB']"
TRANSCRIPTIONAL REGULATION BY TP53,12,"['FAS', 'AKT1', 'TP53', 'FOS', 'CDKN1A', 'BAX', 'GPI', 'MTOR', 'G6PD', 'GSR', 'CREBBP', 'PTEN']"
EXTRA-NUCLEAR ESTROGEN SIGNALING,12,"['AKT1', 'EGFR', 'MAPK1', 'FOS', 'MMP9', 'ESR1', 'MMP2', 'PIK3CA', 'MAPK3', 'BCL2', 'EGF', 'CCND1']"
FOCAL ADHESION,12,"['AKT1', 'EGFR', 'VEGFA', 'MAPK1', 'MAPK8', 'PIK3CA', 'MAPK3', 'BCL2', 'EGF', 'CCND1', 'CRK', 'PTEN']"
ENDOMETRIAL CANCER,12,"['AKT1', 'EGFR', 'TP53', 'MAPK1', 'FOS', 'CDKN1A', 'BAX', 'PIK3CA', 'MAPK3', 'EGF', 'CCND1', 'PTEN']"
ERBB SIGNALING PATHWAY,12,"['AKT1', 'EGFR', 'TP53', 'MAPK1', 'MAPK8', 'CDKN1A', 'PIK3CA', 'MAPK3', 'MTOR', 'EGF', 'CCND1', 'CRK']"
METABOLISM OF LIPIDS,12,"['PPARG', 'ALB', 'POMC', 'PTGS2', 'CYP3A4', 'PIK3CA', 'PPARA', 'AHR', 'GC', 'CREBBP', 'CYP2E1', 'PTEN']"
MEMBRANE TRAFFICKING,11,"['CFTR', 'DCTN4', 'INS', 'SERPINA1', 'AKT1', 'EGFR', 'CD4', 'EGF', 'HGS', 'GRK2', 'APOB']"
MICRORNAS IN CARDIOMYOCYTE HYPERTROPHY,11,"['TGFB1', 'TNF', 'AKT1', 'MAPK1', 'MAPK8', 'STAT3', 'CISH', 'PIK3CA', 'MAPK3', 'MTOR', 'EGF']"
TGF-BETA SIGNALING PATHWAY,11,"['TGFB1', 'AKT1', 'SMAD3', 'TP53', 'MAPK1', 'FOS', 'MAPK8', 'CDKN1A', 'CCND1', 'HGS', 'CREBBP']"
EPITHELIAL TO MESENCHYMAL TRANSITION IN COLORECTAL CANCER,11,"['TGFB1', 'AKT1', 'SMAD3', 'TP53', 'MAPK1', 'MMP9', 'MAPK8', 'MMP2', 'PIK3CA', 'MAPK3', 'HIF1A']"
TNF ALPHA SIGNALING PATHWAY,11,"['TNFRSF1A', 'TNF', 'CCL2', 'AKT1', 'IL6', 'MAPK1', 'MAPK8', 'BAX', 'MAPK3', 'CASP3', 'CREBBP']"
CLASS A/1 (RHODOPSIN-LIKE RECEPTORS),11,"['CXCR1', 'CXCL8', 'CCL2', 'CXCR2', 'C3', 'F2', 'P2RY2', 'POMC', 'RHO', 'SST', 'CCK']"
G ALPHA (I) SIGNALLING EVENTS,11,"['CXCR1', 'CXCL8', 'CXCR2', 'TTR', 'C3', 'MAPK1', 'POMC', 'RHO', 'SST', 'GRK2', 'APOB']"
THYMIC STROMAL LYMPHOPOIETIN (TSLP) SIGNALING PATHWAY,11,"['CXCL8', 'AKT1', 'IL6', 'MAPK1', 'MAPK8', 'RELA', 'STAT3', 'CISH', 'PIK3CA', 'MAPK3', 'MTOR']"
NON-SMALL CELL LUNG CANCER,11,"['AKT1', 'EGFR', 'TP53', 'MAPK1', 'CDKN1A', 'BAX', 'STAT3', 'PIK3CA', 'MAPK3', 'EGF', 'CCND1']"
EGF-EGFR SIGNALING PATHWAY,11,"['AKT1', 'EGFR', 'MAPK1', 'FOS', 'MAPK8', 'STAT3', 'MTOR', 'EGF', 'HGS', 'CRK', 'PTEN']"
PATHWAYS IN CLEAR CELL RENAL CELL CARCINOMA,10,"['TGFB1', 'AKT1', 'EGFR', 'VEGFA', 'STAT3', 'GPI', 'MTOR', 'CREBBP', 'HIF1A', 'PTEN']"
CYTOKINES AND INFLAMMATORY RESPONSE,10,"['TGFB1', 'TNF', 'IL1B', 'IL2', 'IL4', 'IL5', 'IL6', 'CD4', 'IL10', 'IFNG']"
ANTIMICROBIAL PEPTIDES,10,"['CAMP', 'ELANE', 'BPI', 'DEFB1', 'DEFB4A', 'CTSG', 'PRTN3', 'PI3', 'BPIFB1', 'CD4']"
INTERLEUKIN-10 SIGNALING,10,"['TNFRSF1A', 'TNF', 'IL1B', 'CXCL8', 'CCL2', 'TIMP1', 'IL6', 'PTGS2', 'STAT3', 'IL10']"
CELLULAR SENESCENCE,10,"['CXCL8', 'IL6', 'TP53', 'MAPK1', 'FOS', 'MAPK8', 'CDKN1A', 'RELA', 'STAT3', 'MAPK3']"
BLADDER CANCER,10,"['CXCL8', 'EGFR', 'VEGFA', 'TP53', 'MAPK1', 'MMP9', 'CDKN1A', 'MMP2', 'EGF', 'CCND1']"
TOLL LIKE RECEPTOR 4 (TLR4) CASCADE,10,"['TLR4', 'BPI', 'LY96', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3', 'ITGAM']"
EBOLA VIRUS PATHWAY ON HOST,10,"['TLR4', 'GSN', 'AKT1', 'IL4', 'EGFR', 'MAPK1', 'RELA', 'PIK3CA', 'MAPK3', 'CREBBP']"
NEGATIVE REGULATION OF THE PI3K/AKT NETWORK,10,"['INS', 'AKT1', 'EGFR', 'MAPK1', 'ESR1', 'PIK3CA', 'MAPK3', 'EGF', 'KIT', 'PTEN']"
ANDROGEN RECEPTOR NETWORK IN PROSTATE CANCER,10,"['SPINK1', 'MAPK1', 'FOS', 'AR', 'MAPK8', 'STAT3', 'PIK3CA', 'MAPK3', 'CRK', 'PTEN']"
REGULATION OF INSULIN-LIKE GROWTH FACTOR (IGF) TRANSPORT AND UPTAKE BY INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS (IGFBPS),10,"['SERPINA1', 'CTSG', 'TIMP1', 'C3', 'ALB', 'F2', 'IL6', 'MMP2', 'CP', 'APOB']"
TRANSCRIPTIONAL REGULATION BY RUNX2,10,"['AKT1', 'NR3C1', 'MAPK1', 'AR', 'CDKN1A', 'ESR1', 'BAX', 'MAPK3', 'CCND1', 'PSMB6']"
ANDROGEN RECEPTOR SIGNALING PATHWAY,10,"['AKT1', 'EGFR', 'SMAD3', 'AR', 'CDKN1A', 'RELA', 'STAT3', 'CCND1', 'CREBBP', 'PTEN']"
MAPK FAMILY SIGNALING CASCADES,10,"['IL2', 'IL5', 'EGFR', 'IL6', 'MAPK1', 'PIK3CA', 'MAPK3', 'EGF', 'PSMB6', 'KIT']"
MAPK1/MAPK3 SIGNALING,10,"['IL2', 'IL5', 'EGFR', 'IL6', 'MAPK1', 'PIK3CA', 'MAPK3', 'EGF', 'PSMB6', 'KIT']"
CELL CYCLE,9,"['TGFB1', 'AKT1', 'SMAD3', 'TP53', 'MAPK1', 'CDKN1A', 'MAPK3', 'CCND1', 'PSMB6']"
CARDIAC HYPERTROPHIC RESPONSE,9,"['TGFB1', 'TNFRSF1A', 'TNF', 'AKT1', 'MAPK1', 'MAPK8', 'MAPK3', 'MTOR', 'EGF']"
IL-3 SIGNALING PATHWAY,9,"['TGFB1', 'CXCL8', 'AKT1', 'MAPK1', 'FOS', 'MAPK8', 'STAT3', 'MAPK3', 'BCL2']"
CONTROL OF IMMUNE TOLERANCE BY VASOACTIVE INTESTINALPEPTIDE,9,"['TGFB1', 'FAS', 'VIP', 'IL2', 'IL4', 'IL5', 'IL10', 'CTLA4', 'IFNG']"
TGF-BETA RECEPTOR SIGNALING,9,"['TGFB1', 'TNF', 'SMAD3', 'FOS', 'STAT3', 'MAPK3', 'EGF', 'CREBBP', 'IFNG']"
APOPTOSIS MODULATION AND SIGNALING,9,"['TNFRSF1A', 'FAS', 'TP53', 'FOS', 'MAPK8', 'BAX', 'MAPK3', 'CASP3', 'BCL2']"
TNF RELATED WEAK INDUCER OF APOPTOSIS (TWEAK) SIGNALING PATHWAY,9,"['TNF', 'CCL2', 'AKT1', 'IL6', 'MAPK1', 'MMP9', 'MAPK8', 'RELA', 'MAPK3']"
ARYL HYDROCARBON RECEPTOR,9,"['TNF', 'EGFR', 'VEGFA', 'MAPK1', 'CDKN1A', 'ESR1', 'RELA', 'PTGS2', 'AHR']"
INTERLEUKIN-1 FAMILY SIGNALING,9,"['IL1B', 'CTSG', 'IL4', 'NOD2', 'SMAD3', 'MAPK8', 'RELA', 'STAT3', 'PSMB6']"
PEPTIDE LIGAND-BINDING RECEPTORS,9,"['CXCR1', 'CXCL8', 'CCL2', 'CXCR2', 'C3', 'F2', 'POMC', 'SST', 'CCK']"
"PI5P, PP2A AND IER3 REGULATE PI3K/AKT SIGNALING",9,"['INS', 'AKT1', 'EGFR', 'MAPK1', 'ESR1', 'PIK3CA', 'MAPK3', 'EGF', 'KIT']"
FOXO-MEDIATED TRANSCRIPTION,9,"['INS', 'CAT', 'AKT1', 'NR3C1', 'SMAD3', 'POMC', 'CDKN1A', 'CREBBP', 'SOD2']"
CHEMOKINE SIGNALING PATHWAY,9,"['CXCR2', 'AKT1', 'MAPK1', 'RELA', 'STAT3', 'PIK3CA', 'MAPK3', 'GRK2', 'CRK']"
IL-6 SIGNALING PATHWAY,9,"['VIP', 'AKT1', 'TIMP1', 'CRP', 'IL6', 'MAPK1', 'STAT3', 'MAPK3', 'CREBBP']"
INTRINSIC PATHWAY FOR APOPTOSIS,9,"['AKT1', 'TP53', 'MAPK1', 'MAPK8', 'BAX', 'STAT3', 'MAPK3', 'CASP3', 'BCL2']"
SIGNALING BY NOTCH,9,"['AKT1', 'EGFR', 'SMAD3', 'TP53', 'EGF', 'CCND1', 'PSMB6', 'CREBBP', 'HIF1A']"
PI3K/AKT SIGNALING IN CANCER,9,"['AKT1', 'EGFR', 'CDKN1A', 'ESR1', 'PIK3CA', 'MTOR', 'EGF', 'KIT', 'PTEN']"
SIGNALING PATHWAYS IN GLIOBLASTOMA,9,"['AKT1', 'EGFR', 'TP53', 'MAPK1', 'CDKN1A', 'PIK3CA', 'MAPK3', 'CCND1', 'PTEN']"
BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) SIGNALING PATHWAY,9,"['AKT1', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'STAT3', 'MAPK3', 'CASP3', 'MTOR']"
KIT RECEPTOR SIGNALING PATHWAY,9,"['AKT1', 'MAPK1', 'FOS', 'MAPK8', 'STAT3', 'MAPK3', 'BCL2', 'CRK', 'KIT']"
INSULIN SIGNALING,9,"['AKT1', 'MAPK1', 'FOS', 'MAPK8', 'PIK3CA', 'MAPK3', 'MTOR', 'CRK', 'PTEN']"
RAF/MAP KINASE CASCADE,9,"['IL2', 'IL5', 'EGFR', 'MAPK1', 'PIK3CA', 'MAPK3', 'EGF', 'PSMB6', 'KIT']"
FLT3 SIGNALING,9,"['IL2', 'IL5', 'EGFR', 'MAPK1', 'PIK3CA', 'MAPK3', 'EGF', 'PSMB6', 'KIT']"
SUMOYLATION,9,"['NR3C1', 'PPARG', 'TP53', 'AR', 'ESR1', 'RELA', 'PPARA', 'CREBBP', 'PGR']"
SUMO E3 LIGASES SUMOYLATE TARGET PROTEINS,9,"['NR3C1', 'PPARG', 'TP53', 'AR', 'ESR1', 'RELA', 'PPARA', 'CREBBP', 'PGR']"
MIR-TARGETED GENES IN LYMPHOCYTES - TARBASE,9,"['SLC12A2', 'KCNN4', 'EGFR', 'CDKN1A', 'BCL2', 'CCND1', 'G6PD', 'PPIB', 'KIT']"
MIR-TARGETED GENES IN MUSCLE CELL - TARBASE,9,"['SLC12A2', 'EGFR', 'CDKN1A', 'ESR1', 'BCL2', 'CCND1', 'G6PD', 'PPIB', 'KIT']"
MIRNA REGULATION OF PROSTATE CANCER SIGNALING PATHWAYS,9,"['TP53', 'MAPK1', 'AR', 'CDKN1A', 'PIK3CA', 'BCL2', 'MTOR', 'CCND1', 'CREBBP']"
UB-SPECIFIC PROCESSING PROTEASES,8,"['CFTR', 'SMAD3', 'TP53', 'AR', 'HGS', 'PSMB6', 'HIF1A', 'PTEN']"
PLATELET DEGRANULATION ,8,"['TGFB1', 'SERPINA1', 'TIMP1', 'ALB', 'ANXA5', 'VEGFA', 'SOD1', 'EGF']"
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2+,8,"['TGFB1', 'SERPINA1', 'TIMP1', 'ALB', 'ANXA5', 'VEGFA', 'SOD1', 'EGF']"
ARYL HYDROCARBON RECEPTOR PATHWAY,8,"['TGFB1', 'TNF', 'IL1B', 'IL2', 'EGFR', 'BAX', 'AHR', 'IFNG']"
DEGRADATION OF THE EXTRACELLULAR MATRIX,8,"['ELANE', 'CTSG', 'TIMP1', 'PRSS1', 'MMP9', 'MMP2', 'CASP3', 'CD44']"
MIRNAS INVOLVEMENT IN THE IMMUNE RESPONSE IN SEPSIS,8,"['ELANE', 'TNF', 'CXCL8', 'TLR4', 'IL6', 'MAPK8', 'RELA', 'IL10']"
ALZHEIMERS DISEASE,8,"['TNFRSF1A', 'TNF', 'IL1B', 'FAS', 'TP53', 'MAPK1', 'MAPK3', 'CASP3']"
AMYOTROPHIC LATERAL SCLEROSIS (ALS),8,"['TNFRSF1A', 'TNF', 'CAT', 'TP53', 'SOD1', 'BAX', 'CASP3', 'BCL2']"
FIBRIN COMPLEMENT RECEPTOR 3 SIGNALING PATHWAY,8,"['TNF', 'TLR4', 'CCL2', 'AKT1', 'LY96', 'NOS2', 'IL6', 'ITGAM']"
RESISTIN AS A REGULATOR OF INFLAMMATION,8,"['TNF', 'CXCL8', 'AKT1', 'IL6', 'MAPK1', 'RELA', 'PIK3CA', 'MAPK3']"
C-TYPE LECTIN RECEPTORS (CLRS),8,"['MUC5B', 'IL1B', 'MUC4', 'MUC5AC', 'RELA', 'MUC7', 'PSMB6', 'CREBBP']"
IL1 AND MEGAKARYOCYTES IN OBESITY,8,"['IL1B', 'CCL2', 'TIMP1', 'F2', 'NLRP3', 'MMP9', 'PIK3CA', 'IFNG']"
SENESCENCE-ASSOCIATED SECRETORY PHENOTYPE (SASP),8,"['CXCL8', 'IL6', 'MAPK1', 'FOS', 'CDKN1A', 'RELA', 'STAT3', 'MAPK3']"
MYD88:MAL(TIRAP) CASCADE INITIATED ON PLASMA MEMBRANE,8,"['TLR4', 'LY96', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3']"
MYD88-INDEPENDENT TLR4 CASCADE ,8,"['TLR4', 'LY96', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3']"
TOLL LIKE RECEPTOR 9 (TLR9) CASCADE,8,"['TLR4', 'LY96', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3']"
TOLL LIKE RECEPTOR TLR1:TLR2 CASCADE,8,"['TLR4', 'LY96', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3']"
TOLL LIKE RECEPTOR 7/8 (TLR7/8) CASCADE,8,"['TLR4', 'LY96', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3']"
TOLL LIKE RECEPTOR TLR6:TLR2 CASCADE,8,"['TLR4', 'LY96', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3']"
TOLL LIKE RECEPTOR 2 (TLR2) CASCADE,8,"['TLR4', 'LY96', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3']"
TRIF(TICAM1)-MEDIATED TLR4 SIGNALING ,8,"['TLR4', 'LY96', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3']"
TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7/8 OR 9 ACTIVATION,8,"['TLR4', 'LY96', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3']"
MYD88 DEPENDENT CASCADE INITIATED ON ENDOSOME,8,"['TLR4', 'LY96', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3']"
EXTRACELLULAR VESICLES IN THE CROSSTALK OF CARDIAC CELLS,8,"['TLR4', 'EGFR', 'IL6', 'SOD1', 'MMP9', 'STAT3', 'EGF', 'PTEN']"
REGULATION OF ACTIN CYTOSKELETON,8,"['GSN', 'EGFR', 'F2', 'MAPK1', 'PIK3CA', 'MAPK3', 'EGF', 'CRK']"
PTEN REGULATION,8,"['AKT1', 'PPARG', 'TP53', 'MAPK1', 'MAPK3', 'MTOR', 'PSMB6', 'PTEN']"
SIGNALING BY PTK6,8,"['AKT1', 'NR3C1', 'EGFR', 'STAT3', 'EGF', 'CCND1', 'CRK', 'HIF1A']"
SIGNALING BY NON-RECEPTOR TYROSINE KINASES,8,"['AKT1', 'NR3C1', 'EGFR', 'STAT3', 'EGF', 'CCND1', 'CRK', 'HIF1A']"
ESTROGEN-DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR-MEMBRANE SIGNALING,8,"['AKT1', 'EGFR', 'MAPK1', 'FOS', 'MAPK3', 'BCL2', 'EGF', 'CCND1']"
ANGIOGENESIS OVERVIEW,8,"['AKT1', 'VEGFA', 'MAPK1', 'MMP9', 'MAPK8', 'MMP2', 'MTOR', 'CRK']"
ANGIOPOIETIN LIKE PROTEIN 8 REGULATORY PATHWAY,8,"['AKT1', 'MAPK1', 'MAPK8', 'CYP3A4', 'PIK3CA', 'MAPK3', 'MTOR', 'CRK']"
ESC PLURIPOTENCY PATHWAYS,8,"['AKT1', 'EGFR', 'MAPK1', 'FOS', 'STAT3', 'MTOR', 'EGF', 'PTEN']"
IL-4 SIGNALING PATHWAY,8,"['AKT1', 'IL4', 'MAPK1', 'FOS', 'RELA', 'STAT3', 'PIK3CA', 'MAPK3']"
MET IN TYPE 1 PAPILLARY RENAL CELL CARCINOMA,8,"['AKT1', 'MAPK1', 'MAPK8', 'CDKN1A', 'STAT3', 'PIK3CA', 'MAPK3', 'CRK']"
RAS SIGNALING,8,"['AKT1', 'EGFR', 'MAPK1', 'MAPK8', 'RELA', 'PIK3CA', 'MAPK3', 'KIT']"
IL-2 SIGNALING PATHWAY,8,"['AKT1', 'IL2', 'MAPK1', 'FOS', 'STAT3', 'CISH', 'MAPK3', 'BCL2']"
R-HSA-9675108,8,"['EGFR', 'MAPK1', 'MMP9', 'MAPK8', 'MMP2', 'PIK3CA', 'MAPK3', 'PSMB6']"
G ALPHA (Q) SIGNALLING EVENTS,8,"['EGFR', 'F2', 'P2RY2', 'MAPK1', 'PIK3CA', 'MAPK3', 'CCK', 'GRK2']"
AXON GUIDANCE,8,"['EGFR', 'MAPK1', 'MMP9', 'MAPK8', 'MMP2', 'PIK3CA', 'MAPK3', 'PSMB6']"
INTEGRATED BREAST CANCER PATHWAY,8,"['VEGFA', 'MAPK1', 'ESR1', 'BAX', 'CASP3', 'MTOR', 'RHO', 'AHR']"
SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR,8,"['MAPK1', 'FOS', 'MAPK8', 'STAT3', 'PIK3CA', 'MAPK3', 'CRK', 'PTEN']"
DISORDERS OF TRANSMEMBRANE TRANSPORTERS,7,"['CFTR', 'SLC26A3', 'SLC26A4', 'ABCC8', 'CP', 'PSMB6', 'SLC17A5']"
CARGO RECOGNITION FOR CLATHRIN-MEDIATED ENDOCYTOSIS,7,"['CFTR', 'EGFR', 'CD4', 'EGF', 'HGS', 'GRK2', 'APOB']"
CLATHRIN-MEDIATED ENDOCYTOSIS,7,"['CFTR', 'EGFR', 'CD4', 'EGF', 'HGS', 'GRK2', 'APOB']"
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION,7,"['TGFB1', 'TNF', 'LEP', 'PPARG', 'RELA', 'PPARA', 'CREBBP']"
TRANSCRIPTIONAL REGULATION BY RUNX3,7,"['TGFB1', 'SMAD3', 'TP53', 'CDKN1A', 'CCND1', 'PSMB6', 'CREBBP']"
INTERLEUKIN-11 SIGNALING PATHWAY,7,"['TGFB1', 'AKT1', 'MAPK1', 'RELA', 'STAT3', 'MAPK3', 'BCL2']"
DIFFERENTIATION PATHWAY,7,"['TGFB1', 'CXCR1', 'INS', 'IL6', 'VEGFA', 'EGF', 'KIT']"
INTEGRATED LUNG CANCER PATHWAY,7,"['CAMP', 'FAS', 'FOS', 'CASP3', 'MTOR', 'CCND1', 'CRK']"
ION CHANNEL TRANSPORT,7,"['SCNN1B', 'CLCA1', 'SCNN1G', 'ANO1', 'SCNN1A', 'ATP12A', 'MCOLN1']"
OVERVIEW OF NANOPARTICLE EFFECTS,7,"['TNF', 'CXCL8', 'CRP', 'IL6', 'PTGS2', 'BAX', 'BCL2']"
DEVELOPMENT AND HETEROGENEITY OF THE ILC FAMILY,7,"['TNF', 'IL1B', 'IL4', 'IL5', 'IL6', 'AHR', 'IFNG']"
LTF DANGER SIGNAL RESPONSE PATHWAY,7,"['TNF', 'IL1B', 'CXCL8', 'TLR4', 'IFNA1', 'IL6', 'MAPK1']"
IL-1 SIGNALING PATHWAY,7,"['IL1B', 'CCL2', 'AKT1', 'MAPK1', 'MAPK8', 'RELA', 'MAPK3']"
SLC-MEDIATED TRANSMEMBRANE TRANSPORT,7,"['SLC26A9', 'SLC26A3', 'SLC12A2', 'SLC26A4', 'ALB', 'CP', 'SLC17A5']"
TOLL LIKE RECEPTOR 10 (TLR10) CASCADE,7,"['TLR5', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3']"
TOLL LIKE RECEPTOR 5 (TLR5) CASCADE,7,"['TLR5', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3']"
MYD88 CASCADE INITIATED ON PLASMA MEMBRANE,7,"['TLR5', 'NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3']"
POST-TRANSLATIONAL PROTEIN PHOSPHORYLATION,7,"['SERPINA1', 'TIMP1', 'C3', 'ALB', 'IL6', 'CP', 'APOB']"
TP53 REGULATES METABOLIC GENES,7,"['AKT1', 'TP53', 'GPI', 'MTOR', 'G6PD', 'GSR', 'PTEN']"
"CELL CYCLE, MITOTIC",7,"['AKT1', 'TP53', 'MAPK1', 'CDKN1A', 'MAPK3', 'CCND1', 'PSMB6']"
IL-5 SIGNALING PATHWAY,7,"['AKT1', 'IL2', 'MAPK1', 'FOS', 'STAT3', 'MAPK3', 'BCL2']"
RANKL-RANK (RECEPTOR ACTIVATOR OF NFKB (LIGAND)) SIGNALING PATHWAY,7,"['AKT1', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3', 'MTOR']"
HUMAN THYROID STIMULATING HORMONE (TSH) SIGNALING PATHWAY,7,"['AKT1', 'MAPK1', 'FOS', 'STAT3', 'PIK3CA', 'MAPK3', 'MTOR']"
COPPER HOMEOSTASIS,7,"['AKT1', 'TP53', 'SOD1', 'PIK3CA', 'CASP3', 'CCND1', 'PTEN']"
NEOVASCULARISATION PROCESSES,7,"['AKT1', 'SMAD3', 'MAPK1', 'MMP9', 'MAPK8', 'MAPK3', 'KIT']"
"RELATIONSHIP BETWEEN INFLAMMATION, COX-2 AND EGFR",7,"['AKT1', 'EGFR', 'MAPK1', 'ESR1', 'PTGS2', 'PIK3CA', 'MAPK3']"
TRANSCRIPTIONAL REGULATION BY RUNX1,7,"['IL2', 'ESR1', 'CCND1', 'PSMB6', 'CTLA4', 'CREBBP', 'IFNG']"
SIGNALING BY NTRKS,7,"['MAPK1', 'FOS', 'BAX', 'STAT3', 'PIK3CA', 'MAPK3', 'CRK']"
FC EPSILON RECEPTOR (FCERI) SIGNALING,7,"['MAPK1', 'FOS', 'MAPK8', 'RELA', 'PIK3CA', 'MAPK3', 'PSMB6']"
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL,6,"['TGFB1', 'F2', 'PIK3CA', 'ITGAM', 'CD44', 'APOB']"
ACTIVATION OF MATRIX METALLOPROTEINASES,6,"['ELANE', 'CTSG', 'TIMP1', 'PRSS1', 'MMP9', 'MMP2']"
STIMULI-SENSING CHANNELS,6,"['SCNN1B', 'CLCA1', 'SCNN1G', 'ANO1', 'SCNN1A', 'MCOLN1']"
DEATH RECEPTOR SIGNALLING,6,"['TNFRSF1A', 'TNF', 'FAS', 'MAPK8', 'RELA', 'CASP3']"
INFLAMMATORY RESPONSE PATHWAY,6,"['TNFRSF1A', 'IL2', 'IL4', 'IL5', 'CD40', 'IFNG']"
TRANSCRIPTION FACTOR REGULATION IN ADIPOGENESIS,6,"['TNF', 'LEP', 'NR3C1', 'PPARG', 'IL6', 'MAPK8']"
RIG-I-LIKE RECEPTOR SIGNALING,6,"['TNF', 'CXCL8', 'IFNA1', 'MAPK8', 'RELA', 'IFNG']"
NO-CGMP-PKG MEDIATED NEUROPROTECTION,6,"['TNF', 'IL1B', 'NOS2', 'RELA', 'BCL2', 'IFNG']"
PEPTIDE HORMONE METABOLISM,6,"['LEP', 'INS', 'CTSG', 'REN', 'POMC', 'ACE']"
AMP-ACTIVATED PROTEIN KINASE (AMPK) SIGNALING,6,"['LEP', 'AKT1', 'TP53', 'CDKN1A', 'PIK3CA', 'MTOR']"
"FOXO-MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS, METABOLIC AND NEURONAL GENES",6,"['INS', 'CAT', 'NR3C1', 'SMAD3', 'POMC', 'SOD2']"
MIRNA REGULATION OF DNA DAMAGE RESPONSE,6,"['FAS', 'TP53', 'CDKN1A', 'BAX', 'CASP3', 'CCND1']"
DNA DAMAGE RESPONSE,6,"['FAS', 'TP53', 'CDKN1A', 'BAX', 'CASP3', 'CCND1']"
R-HSA-9662851,6,"['PTH', 'VIP', 'SCT', 'IL6', 'POMC', 'IL10']"
R-HSA-9664433,6,"['PTH', 'VIP', 'SCT', 'IL6', 'POMC', 'IL10']"
METABOLISM OF VITAMINS AND COFACTORS,6,"['AKT1', 'TTR', 'PRSS1', 'PTGS2', 'PTS', 'APOB']"
ANGIOGENESIS,6,"['AKT1', 'MAPK1', 'MMP9', 'PIK3CA', 'CREBBP', 'HIF1A']"
WNT SIGNALING PATHWAY,6,"['AKT1', 'PPARG', 'MAPK1', 'MAPK8', 'MTOR', 'CCND1']"
ASSOCIATION BETWEEN PHYSICO-CHEMICAL FEATURES AND TOXICITY ASSOCIATED PATHWAYS,6,"['AKT1', 'EGFR', 'MAPK1', 'SOD1', 'MAPK8', 'CDKN1A']"
ESTROGEN SIGNALING PATHWAY,6,"['AKT1', 'MAPK1', 'FOS', 'ESR1', 'PIK3CA', 'BCL2']"
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY,6,"['NR3C1', 'PPARG', 'AR', 'ESR1', 'PPARA', 'PGR']"
SUMOYLATION OF INTRACELLULAR RECEPTORS,6,"['NR3C1', 'PPARG', 'AR', 'ESR1', 'PPARA', 'PGR']"
NUCLEAR RECEPTORS,6,"['NR3C1', 'PPARG', 'AR', 'ESR1', 'PPARA', 'PGR']"
MIR-TARGETED GENES IN EPITHELIUM - TARBASE,6,"['SLC12A2', 'EGFR', 'CCND1', 'G6PD', 'PPIB', 'KIT']"
TRANSCRIPTIONAL REGULATION BY THE AP-2 (TFAP2) FAMILY OF TRANSCRIPTION FACTORS,6,"['EGFR', 'VEGFA', 'CDKN1A', 'ESR1', 'CREBBP', 'KIT']"
TOLL LIKE RECEPTOR 3 (TLR3) CASCADE,6,"['NOD2', 'MAPK1', 'FOS', 'MAPK8', 'RELA', 'MAPK3']"
PHOTODYNAMIC THERAPY-INDUCED HIF-1 SURVIVAL SIGNALING,6,"['NOS2', 'VEGFA', 'TP53', 'PTGS2', 'BAX', 'HIF1A']"
SIGNALING BY NTRK1 (TRKA),6,"['MAPK1', 'FOS', 'STAT3', 'PIK3CA', 'MAPK3', 'CRK']"
ESTROGEN-DEPENDENT GENE EXPRESSION,6,"['FOS', 'ESR1', 'BCL2', 'CCND1', 'CREBBP', 'PGR']"
SIGNALING BY RHO GTPASES,5,"['CFTR', 'FAM13A', 'MAPK1', 'AR', 'MAPK3']"
EXTRACELLULAR VESICLE-MEDIATED SIGNALING IN RECIPIENT CELLS,5,"['TGFB1', 'AKT1', 'EGFR', 'SMAD3', 'MTOR']"
TYPE 2 PAPILLARY RENAL CELL CARCINOMA,5,"['TGFB1', 'VEGFA', 'CDKN1A', 'CREBBP', 'HIF1A']"
ENDOCHONDRAL OSSIFICATION,5,"['TGFB1', 'PTH', 'AKT1', 'VEGFA', 'MMP9']"
STEROL REGULATORY ELEMENT-BINDING PROTEINS (SREBP) SIGNALLING,5,"['CAMP', 'AKT1', 'PPARG', 'PIK3CA', 'MTOR']"
HUMAN COMPLEMENT SYSTEM,5,"['ELANE', 'C3', 'CRP', 'ALB', 'CD40']"
FACTORS AND PATHWAYS AFFECTING INSULIN-LIKE GROWTH FACTOR (IGF1)-AKT SIGNALING,5,"['TNFRSF1A', 'AKT1', 'SMAD3', 'MTOR', 'PTEN']"
POLYCYSTIC KIDNEY DISEASE PATHWAY,5,"['TNF', 'KCNN4', 'MTOR', 'EGF', 'CCND1']"
EBV LMP1 SIGNALING,5,"['TNF', 'CXCL8', 'MAPK1', 'MAPK8', 'RELA']"
APOPTOSIS-RELATED NETWORK DUE TO ALTERED NOTCH3 IN OVARIAN CANCER,5,"['TNF', 'AKT1', 'ANXA5', 'MAPK1', 'CDKN1A']"
FAS LIGAND (FASL) PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS (HSP) REGULATION,5,"['TNF', 'FAS', 'MAPK8', 'CASP3', 'BCL2']"
VITAMIN D IN INFLAMMATORY DISEASES,5,"['TNF', 'NR3C1', 'SMAD3', 'IL6', 'RELA']"
DISEASES OF METABOLISM,5,"['MUC5B', 'MUC4', 'MUC5AC', 'POMC', 'MUC7']"
R-HSA-9660826,5,"['IL1B', 'CTSG', 'C3', 'NLRP3', 'RELA']"
R-HSA-9664424,5,"['IL1B', 'CTSG', 'C3', 'NLRP3', 'RELA']"
TRANSPORT OF INORGANIC CATIONS/ANIONS AND AMINO ACIDS/OLIGOPEPTIDES,5,"['SLC26A9', 'SLC26A3', 'SLC12A2', 'SLC26A4', 'SLC17A5']"
OXIDATIVE STRESS,5,"['CAT', 'FOS', 'SOD1', 'GSR', 'SOD2']"
R-HSA-9660821,5,"['PTH', 'VIP', 'SCT', 'IL6', 'POMC']"
G ALPHA (S) SIGNALLING EVENTS,5,"['PTH', 'VIP', 'SCT', 'POMC', 'GRK2']"
T-CELL RECEPTOR AND CO-STIMULATORY SIGNALING,5,"['CD8A', 'AKT1', 'IL2', 'CTLA4', 'PTEN']"
SIGNALING BY VEGF,5,"['AKT1', 'VEGFA', 'PIK3CA', 'MTOR', 'CRK']"
COSTIMULATION BY THE CD28 FAMILY,5,"['AKT1', 'CD4', 'PIK3CA', 'MTOR', 'CTLA4']"
VEGFA-VEGFR2 PATHWAY,5,"['AKT1', 'VEGFA', 'PIK3CA', 'MTOR', 'CRK']"
INTEGRIN-MEDIATED CELL ADHESION,5,"['AKT1', 'MAPK1', 'RHO', 'ITGAM', 'CRK']"
REGULATION OF MICROTUBULE CYTOSKELETON,5,"['AKT1', 'STAT3', 'PIK3CA', 'RHO', 'PTEN']"
IL-7 SIGNALING PATHWAY,5,"['AKT1', 'MAPK1', 'STAT3', 'MAPK3', 'CCND1']"
IL17 SIGNALING PATHWAY,5,"['AKT1', 'MAPK1', 'RELA', 'STAT3', 'MAPK3']"
B CELL RECEPTOR SIGNALING PATHWAY,5,"['AKT1', 'MAPK1', 'MAPK8', 'RELA', 'CRK']"
PATHWAYS AFFECTED IN ADENOID CYSTIC CARCINOMA,5,"['AKT1', 'TP53', 'PIK3CA', 'CREBBP', 'PTEN']"
PI3K-AKT-MTOR - VITD3 SIGNALLING,5,"['AKT1', 'RELA', 'IL10', 'PIK3CA', 'MTOR']"
EPO RECEPTOR SIGNALING,5,"['AKT1', 'MAPK1', 'STAT3', 'CISH', 'MAPK3']"
NOTCH SIGNALING PATHWAY,5,"['AKT1', 'CDKN1A', 'STAT3', 'CCND1', 'HIF1A']"
R-HSA-9635486,5,"['CTSG', 'NOS2', 'MAPK1', 'MAPK3', 'HGS']"
R-HSA-9637690,5,"['CTSG', 'NOS2', 'MAPK1', 'MAPK3', 'HGS']"
MAMMARY GLAND DEVELOPMENT PATHWAY - PUBERTY (STAGE 2 OF 4),5,"['TIMP1', 'ESR1', 'EGF', 'CCND1', 'PGR']"
MAMMARY GLAND DEVELOPMENT PATHWAY - PREGNANCY AND LACTATION (STAGE 3 OF 4),5,"['NR3C1', 'EGFR', 'ESR1', 'CCND1', 'PGR']"
SIGNALING BY ERBB4,5,"['EGFR', 'ESR1', 'PIK3CA', 'EGF', 'PGR']"
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER,5,"['EGFR', 'ESR1', 'PIK3CA', 'EGF', 'KIT']"
REGULATION OF PTEN GENE TRANSCRIPTION,5,"['PPARG', 'TP53', 'MAPK1', 'MAPK3', 'MTOR']"
NUCLEAR RECEPTORS IN LIPID METABOLISM AND TOXICITY,5,"['PPARG', 'CYP3A4', 'PPARA', 'ABCB1', 'CYP2E1']"
LIVER STEATOSIS AOP,5,"['PPARG', 'CDKN1A', 'CYP3A4', 'PPARA', 'ABCB1']"
METABOLISM OF STEROIDS,5,"['ALB', 'POMC', 'PPARA', 'GC', 'CREBBP']"
INTERLEUKIN-17 SIGNALING,5,"['NOD2', 'MAPK1', 'FOS', 'MAPK8', 'MAPK3']"
MAP KINASE ACTIVATION,5,"['NOD2', 'MAPK1', 'FOS', 'MAPK8', 'MAPK3']"
CELLULAR RESPONSE TO HEAT STRESS,5,"['HSPA4', 'MAPK1', 'MAPK3', 'MTOR', 'CREBBP']"
OXIDATIVE STRESS INDUCED SENESCENCE,5,"['TP53', 'MAPK1', 'FOS', 'MAPK8', 'MAPK3']"
PRION DISEASE PATHWAY,5,"['MAPK1', 'STAT3', 'MAPK3', 'CASP3', 'BCL2']"
TCR SIGNALING,5,"['CD4', 'RELA', 'PIK3CA', 'PSMB6', 'PTEN']"
DOWNSTREAM TCR SIGNALING,5,"['CD4', 'RELA', 'PIK3CA', 'PSMB6', 'PTEN']"
PDGFR-BETA PATHWAY,5,"['FOS', 'MAPK8', 'STAT3', 'PIK3CA', 'MAPK3']"
INTERLEUKIN-12 FAMILY SIGNALING,5,"['SOD1', 'STAT3', 'IL10', 'SOD2', 'IFNG']"
ORGANELLE BIOGENESIS AND MAINTENANCE,5,"['RHO', 'PPARA', 'CREBBP', 'SOD2', 'BBS9']"
RHO GTPASE EFFECTORS,4,"['CFTR', 'MAPK1', 'AR', 'MAPK3']"
RUNX3 REGULATES CDKN1A TRANSCRIPTION,4,"['TGFB1', 'SMAD3', 'TP53', 'CDKN1A']"
PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS FSGS,4,"['TGFB1', 'TLR4', 'AKT1', 'CDKN1A']"
MAMMARY GLAND DEVELOPMENT PATHWAY - EMBRYONIC DEVELOPMENT (STAGE 1 OF 4),4,"['TGFB1', 'TNF', 'AKT1', 'CCND1']"
NRF2 PATHWAY,4,"['TGFB1', 'SERPINA1', 'G6PD', 'GSR']"
PLATELET-MEDIATED INTERACTIONS WITH VASCULAR AND CIRCULATING CELLS,4,"['TGFB1', 'IL1B', 'CCL2', 'CD40']"
ACE INHIBITOR PATHWAY,4,"['TGFB1', 'CTSG', 'REN', 'ACE']"
COMPLEMENT CASCADE,4,"['ELANE', 'C3', 'CRP', 'F2']"
TNFR2 NON-CANONICAL NF-KB PATHWAY,4,"['TNFRSF1A', 'TNF', 'CD40', 'PSMB6']"
MATRIX METALLOPROTEINASES,4,"['TNF', 'TIMP1', 'MMP9', 'MMP2']"
TYPE II DIABETES MELLITUS,4,"['TNF', 'MAPK1', 'MAPK8', 'MTOR']"
OXIDATIVE DAMAGE,4,"['TNF', 'CDKN1A', 'CASP3', 'BCL2']"
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS (SHR),4,"['DCTN4', 'NR3C1', 'AR', 'PGR']"
ASPARAGINE N-LINKED GLYCOSYLATION,4,"['DCTN4', 'INS', 'SERPINA1', 'SLC17A5']"
DISEASES OF GLYCOSYLATION,4,"['MUC5B', 'MUC4', 'MUC5AC', 'MUC7']"
DISEASES ASSOCIATED WITH O-GLYCOSYLATION OF PROTEINS,4,"['MUC5B', 'MUC4', 'MUC5AC', 'MUC7']"
DEFECTIVE GALNT3 CAUSES FAMILIAL HYPERPHOSPHATEMIC TUMORAL CALCINOSIS (HFTC),4,"['MUC5B', 'MUC4', 'MUC5AC', 'MUC7']"
DEFECTIVE C1GALT1C1 CAUSES TN POLYAGGLUTINATION SYNDROME (TNPS),4,"['MUC5B', 'MUC4', 'MUC5AC', 'MUC7']"
DEFECTIVE GALNT12 CAUSES COLORECTAL CANCER 1 (CRCS1),4,"['MUC5B', 'MUC4', 'MUC5AC', 'MUC7']"
O-LINKED GLYCOSYLATION,4,"['MUC5B', 'MUC4', 'MUC5AC', 'MUC7']"
DECTIN-2 FAMILY,4,"['MUC5B', 'MUC4', 'MUC5AC', 'MUC7']"
O-LINKED GLYCOSYLATION OF MUCINS,4,"['MUC5B', 'MUC4', 'MUC5AC', 'MUC7']"
TERMINATION OF O-GLYCAN BIOSYNTHESIS,4,"['MUC5B', 'MUC4', 'MUC5AC', 'MUC7']"
INTERLEUKIN-1 SIGNALING,4,"['IL1B', 'NOD2', 'RELA', 'PSMB6']"
NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN (NOD) PATHWAY,4,"['IL1B', 'NOD2', 'NLRP3', 'RELA']"
HEMATOPOIETIC STEM CELL DIFFERENTIATION,4,"['IL1B', 'IL5', 'IL6', 'FOS']"
CHEMOKINE RECEPTORS BIND CHEMOKINES,4,"['CXCR1', 'CXCL8', 'CCL2', 'CXCR2']"
"GPCRS, CLASS A RHODOPSIN-LIKE",4,"['CXCR1', 'CXCR2', 'P2RY2', 'RHO']"
LEPTIN INSULIN OVERLAP,4,"['LEP', 'INS', 'AKT1', 'STAT3']"
GLUCOCORTICOID RECEPTOR PATHWAY,4,"['SCNN1A', 'CCL2', 'NR3C1', 'PTGS2']"
DISEASES OF IMMUNE SYSTEM,4,"['TLR4', 'TLR5', 'LY96', 'RELA']"
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY,4,"['TLR4', 'FAS', 'LY96', 'CASP3']"
DISEASES ASSOCIATED WITH THE TLR SIGNALING CASCADE,4,"['TLR4', 'TLR5', 'LY96', 'RELA']"
TOLL-LIKE RECEPTOR SIGNALING,4,"['TLR4', 'TLR5', 'MAPK1', 'RELA']"
INSULIN RECEPTOR SIGNALLING CASCADE,4,"['INS', 'MAPK1', 'PIK3CA', 'MAPK3']"
SIGNALING BY INSULIN RECEPTOR,4,"['INS', 'MAPK1', 'PIK3CA', 'MAPK3']"
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES,4,"['FAS', 'TP53', 'BAX', 'CREBBP']"
NANOMATERIAL INDUCED APOPTOSIS,4,"['FAS', 'BAX', 'CASP3', 'BCL2']"
DETOXIFICATION OF REACTIVE OXYGEN SPECIES,4,"['CAT', 'SOD1', 'GSR', 'SOD2']"
INTERFERON SIGNALING,4,"['IFNA1', 'MAPK3', 'CD44', 'IFNG']"
SLC TRANSPORTER DISORDERS,4,"['SLC26A3', 'SLC26A4', 'CP', 'SLC17A5']"
ACTIVATION OF BH3-ONLY PROTEINS,4,"['AKT1', 'TP53', 'MAPK8', 'BCL2']"
SIGNALING BY ERBB2,4,"['AKT1', 'EGFR', 'PIK3CA', 'EGF']"
MITOTIC G1-G1/S PHASES,4,"['AKT1', 'CDKN1A', 'CCND1', 'PSMB6']"
CYCLIN E ASSOCIATED EVENTS DURING G1/S TRANSITION ,4,"['AKT1', 'CDKN1A', 'CCND1', 'PSMB6']"
G1/S TRANSITION,4,"['AKT1', 'CDKN1A', 'CCND1', 'PSMB6']"
S PHASE,4,"['AKT1', 'CDKN1A', 'CCND1', 'PSMB6']"
CYCLIN A:CDK2-ASSOCIATED EVENTS AT S PHASE ENTRY,4,"['AKT1', 'CDKN1A', 'CCND1', 'PSMB6']"
SIGNALING BY NOTCH4,4,"['AKT1', 'SMAD3', 'PSMB6', 'CREBBP']"
FOLLICLE STIMULATING HORMONE (FSH) SIGNALING PATHWAY,4,"['AKT1', 'MAPK1', 'MAPK3', 'MTOR']"
ALPHA 6 BETA 4 SIGNALING PATHWAY,4,"['AKT1', 'MAPK1', 'MAPK3', 'MTOR']"
PI3K-AKT-MTOR SIGNALING PATHWAY AND THERAPEUTIC OPPORTUNITIES,4,"['AKT1', 'PIK3CA', 'MTOR', 'PTEN']"
"4-HYDROXYTAMOXIFEN, DEXAMETHASONE, AND RETINOIC ACIDS REGULATION OF P27 EXPRESSION",4,"['AKT1', 'MAPK1', 'MAPK3', 'MTOR']"
STEATOSIS AOP,4,"['AKT1', 'PPARG', 'MTOR', 'PPARA']"
INTERLEUKIN-2 FAMILY SIGNALING,4,"['IL2', 'IL5', 'STAT3', 'PIK3CA']"
"INTERLEUKIN-3, INTERLEUKIN-5 AND GM-CSF SIGNALING",4,"['IL2', 'IL5', 'PIK3CA', 'CRK']"
CIRCADIAN CLOCK,4,"['NR3C1', 'PPARA', 'CREBBP', 'HIF1A']"
NEURONAL SYSTEM,4,"['KCNN4', 'ABCC8', 'MAPK1', 'MAPK3']"
MIR-TARGETED GENES IN LEUKOCYTES - TARBASE,4,"['KCNN4', 'BCL2', 'G6PD', 'PPIB']"
SIGNALING BY EGFR,4,"['EGFR', 'PIK3CA', 'EGF', 'HGS']"
TFAP2 (AP-2) FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS,4,"['EGFR', 'VEGFA', 'ESR1', 'KIT']"
TCA CYCLE NUTRIENT UTILIZATION AND INVASIVENESS OF OVARIAN CANCER,4,"['EGFR', 'MAPK1', 'STAT3', 'MAPK3']"
"ERK PATHWAY IN HUNTINGTON,S DISEASE",4,"['EGFR', 'MAPK1', 'CASP3', 'EGF']"
PPARA ACTIVATES GENE EXPRESSION,4,"['PPARG', 'PPARA', 'AHR', 'CREBBP']"
REGULATION OF LIPID METABOLISM BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPARALPHA),4,"['PPARG', 'PPARA', 'AHR', 'CREBBP']"
"NUCLEOTIDE-BINDING DOMAIN, LEUCINE RICH REPEAT CONTAINING RECEPTOR (NLR) SIGNALING PATHWAYS",4,"['NOD2', 'NLRP3', 'RELA', 'BCL2']"
OVARIAN TUMOR DOMAIN PROTEASES,4,"['NOD2', 'TP53', 'ESR1', 'PTEN']"
HYPOTHESIZED PATHWAYS IN PATHOGENESIS OF CARDIOVASCULAR DISEASE,4,"['SMAD3', 'MAPK1', 'MAPK8', 'MAPK3']"
R-HSA-8853884,4,"['IL6', 'TP53', 'RELA', 'CCND1']"
CELLULAR RESPONSE TO HYPOXIA,4,"['VEGFA', 'PSMB6', 'CREBBP', 'HIF1A']"
TP53 NETWORK,4,"['TP53', 'CDKN1A', 'BAX', 'BCL2']"
MAMMARY GLAND DEVELOPMENT PATHWAY - INVOLUTION (STAGE 4 OF 4),4,"['TP53', 'MMP9', 'BAX', 'STAT3']"
LNCRNA-MEDIATED MECHANISMS OF THERAPEUTIC RESISTANCE,4,"['TP53', 'CDKN1A', 'ABCB1', 'HIF1A']"
MIRNA REGULATION OF P53 PATHWAY IN PROSTATE CANCER,4,"['TP53', 'BAX', 'CASP3', 'PTEN']"
WNT SIGNALING PATHWAY AND PLURIPOTENCY,4,"['TP53', 'CCND1', 'CD44', 'CREBBP']"
APOPTOTIC FACTOR-MEDIATED RESPONSE,4,"['MAPK1', 'BAX', 'MAPK3', 'CASP3']"
FCGAMMA RECEPTOR (FCGR) DEPENDENT PHAGOCYTOSIS,4,"['MAPK1', 'PIK3CA', 'MAPK3', 'CRK']"
FCERI MEDIATED MAPK ACTIVATION,4,"['MAPK1', 'FOS', 'MAPK8', 'MAPK3']"
MAPK TARGETS/ NUCLEAR EVENTS MEDIATED BY MAP KINASES,4,"['MAPK1', 'FOS', 'MAPK8', 'MAPK3']"
ACTIVATION OF THE AP-1 FAMILY OF TRANSCRIPTION FACTORS,4,"['MAPK1', 'FOS', 'MAPK8', 'MAPK3']"
GROWTH HORMONE RECEPTOR SIGNALING,4,"['MAPK1', 'STAT3', 'CISH', 'MAPK3']"
OSTEOPONTIN SIGNALING,4,"['MAPK1', 'MMP9', 'RELA', 'MAPK3']"
PHYSIOLOGICAL AND PATHOLOGICAL HYPERTROPHY OF THE HEART,4,"['MAPK1', 'FOS', 'MAPK8', 'STAT3']"
STRUCTURAL PATHWAY OF INTERLEUKIN 1 (IL-1),4,"['MAPK1', 'FOS', 'RELA', 'MAPK3']"
SEROTONIN HTR1 GROUP AND FOS PATHWAY,4,"['MAPK1', 'FOS', 'PIK3CA', 'MAPK3']"
GENE AND PROTEIN EXPRESSION BY JAK-STAT SIGNALING AFTER INTERLEUKIN-12 STIMULATION,4,"['SOD1', 'IL10', 'SOD2', 'IFNG']"
INTERLEUKIN-12 SIGNALING,4,"['SOD1', 'IL10', 'SOD2', 'IFNG']"
BIOLOGICAL OXIDATIONS,4,"['POMC', 'CYP3A4', 'AHR', 'CYP2E1']"
CYTOCHROME P450 - ARRANGED BY SUBSTRATE TYPE,4,"['POMC', 'CYP3A4', 'AHR', 'CYP2E1']"
PHASE I - FUNCTIONALIZATION OF COMPOUNDS,4,"['POMC', 'CYP3A4', 'AHR', 'CYP2E1']"
SIGNALING BY SCF-KIT,4,"['MMP9', 'STAT3', 'PIK3CA', 'KIT']"
SIGNALING BY MET,4,"['STAT3', 'PIK3CA', 'HGS', 'CRK']"
NEDDYLATION,4,"['WDTC1', 'CISH', 'PSMB6', 'HIF1A']"
ABC-FAMILY PROTEINS MEDIATED TRANSPORT,3,"['CFTR', 'ABCB1', 'PSMB6']"
ABC TRANSPORTER DISORDERS,3,"['CFTR', 'ABCC8', 'PSMB6']"
TFS REGULATE MIRNAS RELATED TO CARDIAC HYPERTROPHY,3,"['TGFB1', 'AKT1', 'STAT3']"
CARDIAC PROGENITOR DIFFERENTIATION,3,"['TGFB1', 'INS', 'KIT']"
ENDODERM DIFFERENTIATION,3,"['TGFB1', 'NR3C1', 'SMAD3']"
DOPAMINERGIC NEUROGENESIS,3,"['TGFB1', 'TH', 'STAT3']"
CANONICAL AND NON-CANONICAL TGF-B SIGNALING,3,"['TGFB1', 'SMAD3', 'MAPK8']"
COLLAGEN DEGRADATION,3,"['ELANE', 'MMP9', 'MMP2']"
REGULATION OF COMPLEMENT CASCADE,3,"['ELANE', 'C3', 'F2']"
APOPTOSIS MODULATION BY HSP70,3,"['TNFRSF1A', 'FAS', 'CASP3']"
ROLE ALTERED GLYCOLYSATION OF MUC1 IN TUMOUR MICROENVIRONMENT,3,"['TNF', 'IL6', 'RELA']"
MONOAMINE TRANSPORT,3,"['TNF', 'IL1B', 'TH']"
ER TO GOLGI ANTEROGRADE TRANSPORT,3,"['DCTN4', 'INS', 'SERPINA1']"
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION,3,"['DCTN4', 'INS', 'SERPINA1']"
INTERLEUKIN-1 PROCESSING,3,"['IL1B', 'CTSG', 'RELA']"
CLEC7A (DECTIN-1) SIGNALING,3,"['IL1B', 'RELA', 'PSMB6']"
MYOMETRIAL RELAXATION AND CONTRACTION PATHWAYS,3,"['IL1B', 'IL6', 'FOS']"
TYPE II INTERFERON SIGNALING (IFNG),3,"['IL1B', 'NOS2', 'IFNG']"
MULTIFUNCTIONAL ANION EXCHANGERS,3,"['SLC26A9', 'SLC26A3', 'SLC26A4']"
ER-PHAGOSOME PATHWAY,3,"['TLR4', 'LY96', 'PSMB6']"
ANTIGEN PROCESSING-CROSS PRESENTATION,3,"['TLR4', 'LY96', 'PSMB6']"
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND,3,"['TLR4', 'FAS', 'LY96']"
REGULATION OF TLR BY ENDOGENOUS LIGAND,3,"['TLR4', 'LY96', 'APOB']"
CLASS I MHC MEDIATED ANTIGEN PROCESSING & PRESENTATION,3,"['TLR4', 'LY96', 'PSMB6']"
PATHOGENIC ESCHERICHIA COLI INFECTION,3,"['TLR4', 'TLR5', 'LY96']"
REGULATION OF BETA-CELL DEVELOPMENT,3,"['INS', 'AKT1', 'CREBBP']"
SIGNAL ATTENUATION,3,"['INS', 'MAPK1', 'MAPK3']"
AMYLOID FIBER FORMATION,3,"['INS', 'GSN', 'TTR']"
CORI CYCLE,3,"['INS', 'GPI', 'G6PD']"
WHITE FAT CELL DIFFERENTIATION,3,"['INS', 'NR3C1', 'PPARG']"
TRYPTOPHAN METABOLISM,3,"['CAT', 'CYP3A4', 'CYP2E1']"
DDX58/IFIH1-MEDIATED INDUCTION OF INTERFERON-ALPHA/BETA,3,"['IFNA1', 'RELA', 'CREBBP']"
CLASS B/2 (SECRETIN FAMILY RECEPTORS),3,"['PTH', 'VIP', 'SCT']"
DEFENSINS,3,"['DEFB1', 'DEFB4A', 'CD4']"
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS,3,"['HP', 'ALB', 'APOB']"
GASTRIC ACID PRODUCTION,3,"['VIP', 'SCT', 'CCK']"
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON-LYMPHOID CELL,3,"['CD8A', 'C3', 'CD40']"
DENGUE-2 INTERACTIONS WITH COMPLEMENT AND COAGULATION CASCADES,3,"['SERPINA1', 'C3', 'F2']"
COMPLEMENT AND COAGULATION CASCADES,3,"['SERPINA1', 'C3', 'F2']"
SIGNALING BY WNT,3,"['AKT1', 'PSMB6', 'CREBBP']"
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT,3,"['AKT1', 'PSMB6', 'CREBBP']"
CD28 CO-STIMULATION,3,"['AKT1', 'PIK3CA', 'MTOR']"
CD28 DEPENDENT PI3K/AKT SIGNALING,3,"['AKT1', 'PIK3CA', 'MTOR']"
REGULATION OF TP53 ACTIVITY,3,"['AKT1', 'TP53', 'MTOR']"
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER,3,"['AKT1', 'CDKN1A', 'MTOR']"
REGULATION OF TP53 DEGRADATION,3,"['AKT1', 'TP53', 'MTOR']"
REGULATION OF TP53 EXPRESSION AND DEGRADATION,3,"['AKT1', 'TP53', 'MTOR']"
PLATELET AGGREGATION (PLUG FORMATION),3,"['AKT1', 'F2', 'CRK']"
DOWNREGULATION OF ERBB2 SIGNALING,3,"['AKT1', 'EGFR', 'EGF']"
REGULATION OF PTEN STABILITY AND ACTIVITY,3,"['AKT1', 'PSMB6', 'PTEN']"
SIGNAL TRANSDUCTION OF S1P RECEPTOR,3,"['AKT1', 'MAPK1', 'MAPK3']"
MECP2 AND ASSOCIATED RETT SYNDROME,3,"['AKT1', 'MTOR', 'SST']"
BDNF-TRKB SIGNALING,3,"['AKT1', 'MAPK1', 'MTOR']"
TGF-B SIGNALING IN THYROID CELLS FOR EPITHELIAL-MESENCHYMAL TRANSITION,3,"['AKT1', 'SMAD3', 'MAPK1']"
REGULATION OF APOPTOSIS BY PARATHYROID HORMONE-RELATED PROTEIN,3,"['AKT1', 'BAX', 'BCL2']"
SOMATROPH AXIS (GH) AND ITS RELATIONSHIP TO DIETARY RESTRICTION AND AGING,3,"['AKT1', 'MTOR', 'PTEN']"
CALORIC RESTRICTION AND AGING,3,"['AKT1', 'TP53', 'MTOR']"
IRON UPTAKE AND TRANSPORT,3,"['HFE', 'MCOLN1', 'CP']"
R-HSA-9635465,3,"['CTSG', 'MAPK1', 'MAPK3']"
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS,3,"['CTSG', 'REN', 'ACE']"
ROS AND RNS PRODUCTION IN PHAGOCYTES,3,"['MPO', 'LPO', 'NOS2']"
RUNX1 AND FOXP3 CONTROL THE DEVELOPMENT OF REGULATORY T LYMPHOCYTES (TREGS),3,"['IL2', 'CTLA4', 'IFNG']"
INTERLEUKIN RECEPTOR SHC SIGNALING,3,"['IL2', 'IL5', 'PIK3CA']"
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY,3,"['NR3C1', 'ESR1', 'PSMB6']"
SEROTONIN RECEPTOR 4-6-7 AND NR3C SIGNALING,3,"['NR3C1', 'MAPK1', 'MAPK3']"
OTHER INTERLEUKIN SIGNALING,3,"['PRTN3', 'CD4', 'CASP3']"
VISUAL PHOTOTRANSDUCTION,3,"['TTR', 'RHO', 'APOB']"
TYROBP CAUSAL NETWORK,3,"['C3', 'CD4', 'ITGAM']"
R-HSA-1227990,3,"['EGFR', 'PIK3CA', 'EGF']"
R-HSA-9664565,3,"['EGFR', 'PIK3CA', 'EGF']"
R-HSA-9665348,3,"['EGFR', 'PIK3CA', 'EGF']"
CONSTITUTIVE SIGNALING BY LIGAND-RESPONSIVE EGFR CANCER VARIANTS,3,"['EGFR', 'PIK3CA', 'EGF']"
SIGNALING BY EGFR IN CANCER,3,"['EGFR', 'PIK3CA', 'EGF']"
GAB1 SIGNALOSOME,3,"['EGFR', 'PIK3CA', 'EGF']"
EGFR DOWNREGULATION,3,"['EGFR', 'EGF', 'HGS']"
PI3K EVENTS IN ERBB2 SIGNALING,3,"['EGFR', 'PIK3CA', 'EGF']"
L1CAM INTERACTIONS,3,"['EGFR', 'MAPK1', 'MAPK3']"
SIGNAL TRANSDUCTION BY L1,3,"['EGFR', 'MAPK1', 'MAPK3']"
CONSTITUTIVE SIGNALING BY EGFRVIII,3,"['EGFR', 'PIK3CA', 'EGF']"
SIGNALING BY EGFRVIII IN CANCER,3,"['EGFR', 'PIK3CA', 'EGF']"
SIGNALING BY LIGAND-RESPONSIVE EGFR VARIANTS IN CANCER,3,"['EGFR', 'PIK3CA', 'EGF']"
GASTRIN-CREB SIGNALLING PATHWAY VIA PKC AND MAPK,3,"['EGFR', 'MAPK1', 'MAPK3']"
SIGNALING BY NOTCH3,3,"['EGFR', 'EGF', 'CREBBP']"
TRANSCRIPTIONAL REGULATION BY MECP2,3,"['PPARG', 'SST', 'PTEN']"
PROSTAGLANDIN SYNTHESIS AND REGULATION,3,"['PPARG', 'ANXA5', 'PTGS2']"
REGULATION OF HSF1-MEDIATED HEAT SHOCK RESPONSE,3,"['HSPA4', 'MAPK1', 'MAPK3']"
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS (PARS),3,"['F2', 'MAPK1', 'MAPK3']"
INFLAMMASOMES,3,"['NLRP3', 'RELA', 'BCL2']"
RAF-INDEPENDENT MAPK1/3 ACTIVATION,3,"['IL6', 'MAPK1', 'MAPK3']"
NCRNAS INVOLVED IN STAT3 SIGNALING IN HEPATOCELLULAR CARCINOMA,3,"['IL6', 'RELA', 'STAT3']"
REGULATION OF GENE EXPRESSION BY HYPOXIA-INDUCIBLE FACTOR,3,"['VEGFA', 'CREBBP', 'HIF1A']"
QUERCETIN AND NF-KB- AP-1 INDUCED CELL APOPTOSIS,3,"['VEGFA', 'FOS', 'PTGS2']"
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CARCINOMA PATHWAY,3,"['VEGFA', 'TP53', 'HIF1A']"
PRE-NOTCH TRANSCRIPTION AND TRANSLATION,3,"['TP53', 'CCND1', 'CREBBP']"
PRE-NOTCH EXPRESSION AND PROCESSING,3,"['TP53', 'CCND1', 'CREBBP']"
ONCOGENE INDUCED SENESCENCE,3,"['TP53', 'MAPK1', 'MAPK3']"
MITOTIC G2-G2/M PHASES,3,"['TP53', 'CDKN1A', 'PSMB6']"
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES,3,"['TP53', 'CDKN1A', 'BAX']"
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE,3,"['TP53', 'BAX', 'CREBBP']"
G2/M TRANSITION,3,"['TP53', 'CDKN1A', 'PSMB6']"
P53-DEPENDENT G1 DNA DAMAGE RESPONSE,3,"['TP53', 'CDKN1A', 'PSMB6']"
P53-DEPENDENT G1/S DNA DAMAGE CHECKPOINT,3,"['TP53', 'CDKN1A', 'PSMB6']"
G1/S DNA DAMAGE CHECKPOINTS,3,"['TP53', 'CDKN1A', 'PSMB6']"
CELL CYCLE CHECKPOINTS,3,"['TP53', 'CDKN1A', 'PSMB6']"
THE ROLE OF GTSE1 IN G2/M PROGRESSION AFTER G2 CHECKPOINT,3,"['TP53', 'CDKN1A', 'PSMB6']"
MIRNAS INVOLVED IN DNA DAMAGE RESPONSE,3,"['TP53', 'CDKN1A', 'CCND1']"
RETINOBLASTOMA GENE IN CANCER,3,"['TP53', 'CDKN1A', 'CCND1']"
G1 TO S CELL CYCLE CONTROL,3,"['TP53', 'CDKN1A', 'CCND1']"
R-HSA-9664407,3,"['MAPK1', 'MAPK3', 'CRK']"
R-HSA-9664417,3,"['MAPK1', 'MAPK3', 'CRK']"
R-HSA-9664422,3,"['MAPK1', 'MAPK3', 'CRK']"
CYTOCHROME C-MEDIATED APOPTOTIC RESPONSE,3,"['MAPK1', 'MAPK3', 'CASP3']"
OPIOID SIGNALLING,3,"['MAPK1', 'POMC', 'GRK2']"
PROLONGED ERK ACTIVATION EVENTS,3,"['MAPK1', 'MAPK3', 'CRK']"
SIGNALLING TO ERKS,3,"['MAPK1', 'MAPK3', 'CRK']"
SIGNALING BY FGFR,3,"['MAPK1', 'PIK3CA', 'MAPK3']"
NUCLEAR EVENTS (KINASE AND TRANSCRIPTION FACTOR ACTIVATION),3,"['MAPK1', 'FOS', 'MAPK3']"
REGULATION OF ACTIN DYNAMICS FOR PHAGOCYTIC CUP FORMATION,3,"['MAPK1', 'MAPK3', 'CRK']"
SIGNALING BY FGFR1,3,"['MAPK1', 'PIK3CA', 'MAPK3']"
SIGNALING BY FGFR2,3,"['MAPK1', 'PIK3CA', 'MAPK3']"
SIGNALING BY FGFR3,3,"['MAPK1', 'PIK3CA', 'MAPK3']"
SIGNALING BY FGFR4,3,"['MAPK1', 'PIK3CA', 'MAPK3']"
M PHASE,3,"['MAPK1', 'MAPK3', 'PSMB6']"
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION,3,"['MAPK1', 'AR', 'MAPK3']"
RUNX2 REGULATES BONE DEVELOPMENT,3,"['MAPK1', 'AR', 'MAPK3']"
IL-9 SIGNALING PATHWAY,3,"['MAPK1', 'STAT3', 'MAPK3']"
NIFEDIPINE ACTIVITY,3,"['MAPK1', 'SOD1', 'CYP3A4']"
INHIBITION OF EXOSOME BIOGENESIS AND SECRETION BY MANUMYCIN A IN CRPC CELLS,3,"['MAPK1', 'MAPK3', 'HGS']"
METABOLISM OF AMINO ACIDS AND DERIVATIVES,3,"['TH', 'GSR', 'PSMB6']"
ONE CARBON METABOLISM AND RELATED PATHWAYS,3,"['SOD1', 'GSR', 'SOD2']"
AOP CYP2E1 ACTIVATION LEADING TO NEURODEGENERATION,3,"['SOD1', 'MAPK8', 'BCL2']"
P75 NTR RECEPTOR-MEDIATED SIGNALLING,3,"['MAPK8', 'RELA', 'CASP3']"
NLR PROTEINS,3,"['MAPK8', 'RELA', 'CD40']"
SCF(SKP2)-MEDIATED DEGRADATION OF P27/P21,3,"['CDKN1A', 'CCND1', 'PSMB6']"
ESTROGEN RECEPTOR PATHWAY,3,"['ESR1', 'STAT3', 'PPARA']"
CHROMATIN MODIFYING ENZYMES,3,"['RELA', 'CCND1', 'CREBBP']"
CHROMATIN ORGANIZATION,3,"['RELA', 'CCND1', 'CREBBP']"
BIOSYNTHESIS OF DHA-DERIVED SPMS,3,"['PTGS2', 'CYP3A4', 'CYP2E1']"
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS (SPMS),3,"['PTGS2', 'CYP3A4', 'CYP2E1']"
R-HSA-9669938,3,"['STAT3', 'PIK3CA', 'KIT']"
R-HSA-9670439,3,"['STAT3', 'PIK3CA', 'KIT']"
DOWNSTREAM SIGNAL TRANSDUCTION,3,"['STAT3', 'PIK3CA', 'CRK']"
SIGNALING BY PDGF,3,"['STAT3', 'PIK3CA', 'CRK']"
INTERFERON TYPE I SIGNALING PATHWAYS,3,"['STAT3', 'MTOR', 'CRK']"
XENOBIOTICS,3,"['CYP3A4', 'AHR', 'CYP2E1']"
METAPATHWAY BIOTRANSFORMATION PHASE I AND II,3,"['CYP3A4', 'GSR', 'CYP2E1']"
METABOLISM OF CARBOHYDRATES,3,"['GPI', 'G6PD', 'CD44']"
HEMATOPOIETIC STEM CELL GENE REGULATION BY GABP ALPHA-BETA COMPLEX,3,"['BCL2', 'CREBBP', 'PTEN']"
HEDGEHOG SIGNALING PATHWAY,3,"['BCL2', 'CCND1', 'GRK2']"
MITOCHONDRIAL BIOGENESIS,3,"['PPARA', 'CREBBP', 'SOD2']"
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS,3,"['PPARA', 'CREBBP', 'SOD2']"
MACROAUTOPHAGY,2,"['CFTR', 'MTOR']"
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS,2,"['CFTR', 'PSMB6']"
AUTOPHAGY,2,"['CFTR', 'MTOR']"
SIGNALING BY TGF-BETA RECEPTOR COMPLEX,2,"['TGFB1', 'SMAD3']"
DOWNREGULATION OF TGF-BETA RECEPTOR SIGNALING,2,"['TGFB1', 'SMAD3']"
TGF-BETA RECEPTOR SIGNALING ACTIVATES SMADS,2,"['TGFB1', 'SMAD3']"
NON-INTEGRIN MEMBRANE-ECM INTERACTIONS,2,"['TGFB1', 'TTR']"
LOSS OF FUNCTION OF SMAD2/3 IN CANCER,2,"['TGFB1', 'SMAD3']"
SIGNALING BY TGF-BETA RECEPTOR COMPLEX IN CANCER,2,"['TGFB1', 'SMAD3']"
SMAD2/3 PHOSPHORYLATION MOTIF MUTANTS IN CANCER,2,"['TGFB1', 'SMAD3']"
TGFBR1 KD MUTANTS IN CANCER,2,"['TGFB1', 'SMAD3']"
LOSS OF FUNCTION OF TGFBR1 IN CANCER,2,"['TGFB1', 'SMAD3']"
UCH PROTEINASES,2,"['TGFB1', 'PSMB6']"
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY,2,"['TGFB1', 'PSMB6']"
RUNX3 REGULATES P14-ARF,2,"['TGFB1', 'CCND1']"
SIGNALING BY TGF-BETA FAMILY MEMBERS,2,"['TGFB1', 'SMAD3']"
SIMPLIFIED INTERACTION MAP BETWEEN LOXL4 AND OXIDATIVE STRESS PATHWAY,2,"['TGFB1', 'ANXA5']"
TNFR1-INDUCED PROAPOPTOTIC SIGNALING,2,"['TNFRSF1A', 'TNF']"
REGULATION OF TNFR1 SIGNALING,2,"['TNFRSF1A', 'TNF']"
TNFR1-INDUCED NFKAPPAB SIGNALING PATHWAY,2,"['TNFRSF1A', 'TNF']"
TNFR1-MEDIATED CERAMIDE PRODUCTION,2,"['TNFRSF1A', 'TNF']"
TNF SIGNALING,2,"['TNFRSF1A', 'TNF']"
NANOPARTICLE TRIGGERED REGULATED NECROSIS,2,"['TNFRSF1A', 'MAPK8']"
COPI-MEDIATED ANTEROGRADE TRANSPORT,2,"['DCTN4', 'INS']"
CLEC7A/INFLAMMASOME PATHWAY,2,"['IL1B', 'RELA']"
NANOMATERIAL INDUCED INFLAMMASOME ACTIVATION,2,"['IL1B', 'TLR4']"
"GPCRS, OTHER",2,"['CXCR1', 'CXCR2']"
PEPTIDE GPCRS,2,"['CXCR1', 'CXCR2']"
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM  STRESS,2,"['CXCL8', 'CCL2']"
PERK REGULATES GENE EXPRESSION,2,"['CXCL8', 'CCL2']"
UNFOLDED PROTEIN RESPONSE (UPR),2,"['CXCL8', 'CCL2']"
ATF4 ACTIVATES GENES,2,"['CXCL8', 'CCL2']"
SIGNALING BY LEPTIN,2,"['LEP', 'STAT3']"
"SYNTHESIS, SECRETION, AND DEACYLATION OF GHRELIN",2,"['LEP', 'INS']"
DIFFERENTIATION OF WHITE AND BROWN ADIPOCYTE,2,"['LEP', 'PPARG']"
TRIF-MEDIATED PROGRAMMED CELL DEATH,2,"['TLR4', 'LY96']"
MYD88 DEFICIENCY (TLR2/4),2,"['TLR4', 'LY96']"
IRAK4 DEFICIENCY (TLR2/4),2,"['TLR4', 'LY96']"
ACTIVATION OF IRF3/IRF7 MEDIATED BY TBK1/IKK EPSILON,2,"['TLR4', 'LY96']"
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1,2,"['TLR4', 'LY96']"
TRAF6-MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX,2,"['TLR4', 'LY96']"
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7/8 OR 9 STIMULATION,2,"['TLR4', 'LY96']"
TLR4 SIGNALING AND TOLERANCE,2,"['TLR4', 'IL6']"
SIMPLIFIED DEPICTION OF MYD88 DISTINCT INPUT-OUTPUT PATHWAY,2,"['TLR4', 'TLR5']"
APOE AND MIR-146 IN INFLAMMATION AND ATHEROSCLEROSIS,2,"['TLR4', 'RELA']"
INTEGRATION OF ENERGY METABOLISM,2,"['INS', 'ABCC8']"
REGULATION OF GENE EXPRESSION IN BETA CELLS,2,"['INS', 'AKT1']"
REGULATION OF INSULIN SECRETION,2,"['INS', 'ABCC8']"
TP53 REGULATES TRANSCRIPTION OF DEATH RECEPTORS AND LIGANDS,2,"['FAS', 'TP53']"
PEROXISOMAL PROTEIN IMPORT,2,"['CAT', 'NOS2']"
PROTEIN LOCALIZATION,2,"['CAT', 'NOS2']"
TRAF6 MEDIATED IRF7 ACTIVATION,2,"['IFNA1', 'CREBBP']"
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION,2,"['IFNA1', 'TP53']"
VITAMIN D METABOLISM,2,"['PTH', 'GC']"
BETA DEFENSINS,2,"['DEFB1', 'DEFB4A']"
SCAVENGING OF HEME FROM PLASMA,2,"['HP', 'ALB']"
GLUCAGON-TYPE LIGAND RECEPTORS,2,"['VIP', 'SCT']"
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS,2,"['GSN', 'CASP3']"
CASPASE-MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS,2,"['GSN', 'CASP3']"
APOPTOTIC EXECUTION PHASE,2,"['GSN', 'CASP3']"
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA ,2,"['AKT1', 'BCL2']"
"TETRAHYDROBIOPTERIN (BH4) SYNTHESIS, RECYCLING, SALVAGE AND REGULATION",2,"['AKT1', 'PTS']"
MTOR SIGNALLING,2,"['AKT1', 'MTOR']"
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL,2,"['AKT1', 'CDKN1A']"
INTEGRIN ALPHAIIB BETA3 SIGNALING,2,"['AKT1', 'CRK']"
CTLA4 INHIBITORY SIGNALING,2,"['AKT1', 'CTLA4']"
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU-RICH ELEMENTS,2,"['AKT1', 'PSMB6']"
VEGFR2 MEDIATED VASCULAR PERMEABILITY,2,"['AKT1', 'MTOR']"
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION,2,"['AKT1', 'TP53']"
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO-FACTORS,2,"['AKT1', 'TP53']"
METABOLISM OF RNA,2,"['AKT1', 'PSMB6']"
METABOLISM OF COFACTORS,2,"['AKT1', 'PTS']"
NEGATIVE REGULATION OF NOTCH4 SIGNALING,2,"['AKT1', 'PSMB6']"
TARGET OF RAPAMYCIN (TOR) SIGNALING,2,"['AKT1', 'MTOR']"
TRANSFERRIN ENDOCYTOSIS AND RECYCLING,2,"['HFE', 'MCOLN1']"
PASSIVE TRANSPORT BY AQUAPORINS,2,"['AQP2', 'AQP5']"
AQUAPORIN-MEDIATED TRANSPORT,2,"['AQP2', 'AQP5']"
EVENTS ASSOCIATED WITH PHAGOCYTOLYTIC ACTIVITY OF PMN CELLS,2,"['MPO', 'LPO']"
BENZENE METABOLISM,2,"['MPO', 'CYP2E1']"
R-HSA-9679191,2,"['NR3C1', 'VEGFA']"
R-HSA-9679506,2,"['NR3C1', 'VEGFA']"
PTK6 EXPRESSION,2,"['NR3C1', 'HIF1A']"
COMMON PATHWAY OF FIBRIN CLOT FORMATION,2,"['PRTN3', 'F2']"
FORMATION OF FIBRIN CLOT (CLOTTING CASCADE),2,"['PRTN3', 'F2']"
THE CANONICAL RETINOID CYCLE IN RODS (TWILIGHT VISION),2,"['TTR', 'RHO']"
METABOLISM OF FAT-SOLUBLE VITAMINS,2,"['TTR', 'APOB']"
RETINOID METABOLISM AND TRANSPORT,2,"['TTR', 'APOB']"
INITIAL TRIGGERING OF COMPLEMENT,2,"['C3', 'CRP']"
POTASSIUM CHANNELS,2,"['KCNN4', 'ABCC8']"
R-HSA-9665686,2,"['EGFR', 'EGF']"
SHC1 EVENTS IN ERBB2 SIGNALING,2,"['EGFR', 'EGF']"
PLCG1 EVENTS IN ERBB2 SIGNALING,2,"['EGFR', 'EGF']"
GRB2 EVENTS IN EGFR SIGNALING,2,"['EGFR', 'EGF']"
SHC1 EVENTS IN EGFR SIGNALING,2,"['EGFR', 'EGF']"
GRB2 EVENTS IN ERBB2 SIGNALING,2,"['EGFR', 'EGF']"
EGFR INTERACTS WITH PHOSPHOLIPASE C-GAMMA,2,"['EGFR', 'EGF']"
SIGNALING BY OVEREXPRESSED WILD-TYPE EGFR IN CANCER,2,"['EGFR', 'EGF']"
INHIBITION OF SIGNALING BY OVEREXPRESSED EGFR,2,"['EGFR', 'EGF']"
ERBB2 REGULATES CELL MOTILITY,2,"['EGFR', 'EGF']"
ERBB2 ACTIVATES PTK6 SIGNALING,2,"['EGFR', 'EGF']"
PTK6 PROMOTES HIF1A STABILIZATION,2,"['EGFR', 'HIF1A']"
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS,2,"['EGFR', 'EGF']"
GASTRIC CANCER NETWORK 2,2,"['EGFR', 'TP53']"
HAIR FOLLICLE DEVELOPMENT- INDUCTION (PART 1 OF 3),2,"['EGFR', 'EGF']"
BMP SIGNALING PATHWAY IN EYELID DEVELOPMENT,2,"['EGFR', 'MAPK3']"
ENERGY METABOLISM,2,"['PPARG', 'PPARA']"
HIF1A AND PPARG REGULATION OF GLYCOLYSIS,2,"['PPARG', 'HIF1A']"
"NAD METABOLISM, SIRTUINS AND AGING",2,"['PPARG', 'HIF1A']"
PPAR SIGNALING PATHWAY,2,"['PPARG', 'PPARA']"
THERMOGENESIS,2,"['PPARG', 'MTOR']"
"PLASMA LIPOPROTEIN ASSEMBLY, REMODELING, AND CLEARANCE",2,"['ALB', 'APOB']"
PLASMA LIPOPROTEIN REMODELING,2,"['ALB', 'APOB']"
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX,2,"['NOD2', 'RELA']"
JNK (C-JUN KINASES) PHOSPHORYLATION AND  ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1,2,"['NOD2', 'MAPK8']"
METABOLISM OF WATER-SOLUBLE VITAMINS AND COFACTORS,2,"['PRSS1', 'PTGS2']"
R-HSA-9637687,2,"['NOS2', 'HGS']"
PLATELET HOMEOSTASIS,2,"['NOS2', 'APOB']"
INTERLEUKIN-37 SIGNALING,2,"['SMAD3', 'STAT3']"
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,2,"['SMAD3', 'CREBBP']"
FOXO-MEDIATED TRANSCRIPTION OF CELL CYCLE GENES,2,"['SMAD3', 'CDKN1A']"
MESODERMAL COMMITMENT PATHWAY,2,"['SMAD3', 'CCND1']"
OVARIAN INFERTILITY GENES,2,"['SMAD3', 'PGR']"
THE NLRP3 INFLAMMASOME,2,"['NLRP3', 'RELA']"
R-HSA-9662834,2,"['IL6', 'IL10']"
INTERLEUKIN-6 SIGNALING,2,"['IL6', 'STAT3']"
MAPK3 (ERK1) ACTIVATION,2,"['IL6', 'MAPK3']"
MAPK1 (ERK2) ACTIVATION,2,"['IL6', 'MAPK1']"
INTERLEUKIN-6 FAMILY SIGNALING,2,"['IL6', 'STAT3']"
HEART DEVELOPMENT,2,"['VEGFA', 'MAPK1']"
MICRORNA FOR TARGETING CANCER GROWTH AND VASCULARIZATION IN GLIOBLASTOMA,2,"['VEGFA', 'HIF1A']"
HYPERTROPHY MODEL,2,"['VEGFA', 'IFNG']"
DNA DAMAGE/TELOMERE STRESS INDUCED SENESCENCE,2,"['TP53', 'CDKN1A']"
AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1,2,"['TP53', 'PSMB6']"
CHAPERONIN-MEDIATED PROTEIN FOLDING,2,"['TP53', 'STAT3']"
ASSOCIATION OF TRIC/CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS,2,"['TP53', 'STAT3']"
PROTEIN FOLDING,2,"['TP53', 'STAT3']"
DNA DOUBLE-STRAND BREAK REPAIR,2,"['TP53', 'MAPK8']"
RECRUITMENT AND ATM-MEDIATED PHOSPHORYLATION OF REPAIR AND SIGNALING PROTEINS AT DNA DOUBLE STRAND BREAKS,2,"['TP53', 'MAPK8']"
DNA DOUBLE STRAND BREAK RESPONSE,2,"['TP53', 'MAPK8']"
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES,2,"['TP53', 'FOS']"
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST,2,"['TP53', 'BAX']"
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST,2,"['TP53', 'CDKN1A']"
G2/M CHECKPOINTS,2,"['TP53', 'PSMB6']"
STABILIZATION OF P53,2,"['TP53', 'PSMB6']"
TRANSCRIPTIONAL ACTIVATION OF P53 RESPONSIVE GENES  ,2,"['TP53', 'CDKN1A']"
TRANSCRIPTIONAL  ACTIVATION OF  CELL CYCLE INHIBITOR P21 ,2,"['TP53', 'CDKN1A']"
DNA REPAIR,2,"['TP53', 'MAPK8']"
ATM SIGNALING PATHWAY,2,"['TP53', 'CDKN1A']"
FERROPTOSIS,2,"['TP53', 'CP']"
MICRORNA NETWORK ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA,2,"['TP53', 'BCL2']"
R-HSA-9649948,2,"['MAPK1', 'MAPK3']"
R-HSA-9652169,2,"['MAPK1', 'MAPK3']"
R-HSA-9656223,2,"['MAPK1', 'MAPK3']"
FORMATION OF APOPTOSOME,2,"['MAPK1', 'MAPK3']"
CA-DEPENDENT EVENTS,2,"['MAPK1', 'GRK2']"
G-PROTEIN MEDIATED EVENTS,2,"['MAPK1', 'GRK2']"
PLC BETA MEDIATED EVENTS,2,"['MAPK1', 'GRK2']"
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION,2,"['MAPK1', 'MAPK3']"
TRANSMISSION ACROSS CHEMICAL SYNAPSES,2,"['MAPK1', 'MAPK3']"
SPRY REGULATION OF FGF SIGNALING,2,"['MAPK1', 'MAPK3']"
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION,2,"['MAPK1', 'MAPK3']"
FRS2-MEDIATED ACTIVATION,2,"['MAPK1', 'MAPK3']"
ERK/MAPK TARGETS,2,"['MAPK1', 'MAPK3']"
ERKS ARE INACTIVATED,2,"['MAPK1', 'MAPK3']"
NCAM SIGNALING FOR NEURITE OUT-GROWTH,2,"['MAPK1', 'MAPK3']"
POST NMDA RECEPTOR ACTIVATION EVENTS,2,"['MAPK1', 'MAPK3']"
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR-MEDIATED ACTIVATION OF RAS SIGNALING,2,"['MAPK1', 'MAPK3']"
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS,2,"['MAPK1', 'MAPK3']"
RSK ACTIVATION,2,"['MAPK1', 'MAPK3']"
NEGATIVE REGULATION OF FGFR1 SIGNALING,2,"['MAPK1', 'MAPK3']"
NEGATIVE REGULATION OF FGFR2 SIGNALING,2,"['MAPK1', 'MAPK3']"
NEGATIVE REGULATION OF FGFR3 SIGNALING,2,"['MAPK1', 'MAPK3']"
NEGATIVE REGULATION OF FGFR4 SIGNALING,2,"['MAPK1', 'MAPK3']"
RHO GTPASES ACTIVATE WASPS AND WAVES,2,"['MAPK1', 'MAPK3']"
RHO GTPASES ACTIVATE NADPH OXIDASES,2,"['MAPK1', 'MAPK3']"
MAP2K AND MAPK ACTIVATION,2,"['MAPK1', 'MAPK3']"
NEGATIVE FEEDBACK REGULATION OF MAPK PATHWAY,2,"['MAPK1', 'MAPK3']"
NEGATIVE REGULATION OF MAPK PATHWAY,2,"['MAPK1', 'MAPK3']"
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS,2,"['MAPK1', 'MAPK3']"
SIGNALING BY HIGH-KINASE ACTIVITY BRAF MUTANTS,2,"['MAPK1', 'MAPK3']"
SIGNALING BY RAS MUTANTS,2,"['MAPK1', 'MAPK3']"
SIGNALING BY BRAF AND RAF FUSIONS,2,"['MAPK1', 'MAPK3']"
PARADOXICAL ACTIVATION OF RAF SIGNALING BY KINASE INACTIVE BRAF,2,"['MAPK1', 'MAPK3']"
ONCOGENIC MAPK SIGNALING,2,"['MAPK1', 'MAPK3']"
MITOTIC PROPHASE,2,"['MAPK1', 'MAPK3']"
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING,2,"['MAPK1', 'MAPK3']"
REGULATION OF THE APOPTOSOME ACTIVITY,2,"['MAPK1', 'MAPK3']"
PDGF PATHWAY,2,"['MAPK1', 'MAPK3']"
COMMON PATHWAYS UNDERLYING DRUG ADDICTION,2,"['MAPK1', 'MAPK3']"
MFAP5-MEDIATED OVARIAN CANCER CELL MOTILITY AND INVASIVENESS,2,"['MAPK1', 'MAPK3']"
MAPK CASCADE,2,"['MAPK1', 'MAPK3']"
VITAMIN A AND CAROTENOID METABOLISM,2,"['MAPK1', 'CYP2E1']"
SEROTONIN RECEPTOR 2 AND ELK-SRF-GATA4 SIGNALING,2,"['MAPK1', 'MAPK3']"
PARKINSONS DISEASE PATHWAY,2,"['TH', 'CASP3']"
DOPAMINE METABOLISM,2,"['TH', 'SOD1']"
AMINO ACID METABOLISM,2,"['TH', 'GSR']"
HIV INFECTION,2,"['CD4', 'PSMB6']"
HOST INTERACTIONS OF HIV FACTORS,2,"['CD4', 'PSMB6']"
VPU MEDIATED DEGRADATION OF CD4,2,"['CD4', 'PSMB6']"
SELENIUM METABOLISM AND SELENOPROTEINS,2,"['FOS', 'RELA']"
PHOTODYNAMIC THERAPY-INDUCED NFE2L2 (NRF2) SURVIVAL SIGNALING,2,"['FOS', 'MAPK8']"
SEROTONIN AND ANXIETY,2,"['FOS', 'POMC']"
ENDOGENOUS STEROLS,2,"['POMC', 'AHR']"
COLLAGEN FORMATION,2,"['MMP9', 'PPIB']"
EPH-EPHRIN SIGNALING,2,"['MMP9', 'MMP2']"
EPH-EPHRIN MEDIATED REPULSION OF CELLS,2,"['MMP9', 'MMP2']"
"CELL DEATH SIGNALLING VIA NRAGE, NRIF AND NADE",2,"['MAPK8', 'CASP3']"
PHYTOCHEMICAL ACTIVITY ON NRF2 TRANSCRIPTIONAL ACTIVATION,2,"['MAPK8', 'PIK3CA']"
ETHANOL METABOLISM RESULTING IN PRODUCTION OF ROS BY CYP2E1,2,"['MAPK8', 'CYP2E1']"
WNT SIGNALING,2,"['MAPK8', 'CCND1']"
NRF2-ARE REGULATION,2,"['MAPK8', 'PIK3CA']"
R-HSA-9659787,2,"['CDKN1A', 'CCND1']"
R-HSA-9661069,2,"['CDKN1A', 'CCND1']"
R-HSA-9675126,2,"['CDKN1A', 'CCND1']"
R-HSA-9687139,2,"['CDKN1A', 'CCND1']"
CYCLIN D ASSOCIATED EVENTS IN G1,2,"['CDKN1A', 'CCND1']"
G1 PHASE,2,"['CDKN1A', 'CCND1']"
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS,2,"['CDKN1A', 'STAT3']"
NUCLEAR SIGNALING BY ERBB4,2,"['ESR1', 'PGR']"
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR (BCR),2,"['RELA', 'PSMB6']"
ACTIVATION OF NF-KAPPAB IN B CELLS,2,"['RELA', 'PSMB6']"
CYTOSOLIC SENSORS OF PATHOGEN-ASSOCIATED DNA ,2,"['RELA', 'CREBBP']"
FCERI MEDIATED NF-KB ACTIVATION,2,"['RELA', 'PSMB6']"
DECTIN-1 MEDIATED NONCANONICAL NF-KB SIGNALING,2,"['RELA', 'PSMB6']"
CD209 (DC-SIGN) SIGNALING,2,"['RELA', 'CREBBP']"
SIGNALING BY THE B CELL RECEPTOR (BCR),2,"['RELA', 'PSMB6']"
INITIATION OF TRANSCRIPTION AND TRANSLATION ELONGATION AT THE HIV-1 LTR,2,"['RELA', 'CREBBP']"
SIGNALING BY NTRK3 (TRKC),2,"['BAX', 'PIK3CA']"
R-HSA-9671555,2,"['STAT3', 'PIK3CA']"
R-HSA-9673767,2,"['STAT3', 'PIK3CA']"
R-HSA-9673770,2,"['STAT3', 'PIK3CA']"
BH3-ONLY PROTEINS ASSOCIATE WITH AND INACTIVATE ANTI-APOPTOTIC BCL-2 MEMBERS,2,"['STAT3', 'BCL2']"
SIGNALING BY FGFR IN DISEASE,2,"['STAT3', 'PIK3CA']"
INTERLEUKIN-7 SIGNALING,2,"['STAT3', 'CISH']"
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS,2,"['STAT3', 'PIK3CA']"
FGFR1 MUTANT RECEPTOR ACTIVATION,2,"['STAT3', 'PIK3CA']"
SIGNALING BY FGFR1 IN DISEASE,2,"['STAT3', 'PIK3CA']"
BIOSYNTHESIS OF MARESINS,2,"['CYP3A4', 'CYP2E1']"
BIOSYNTHESIS OF MARESIN-LIKE SPMS,2,"['CYP3A4', 'CYP2E1']"
CODEINE AND MORPHINE METABOLISM,2,"['CYP3A4', 'ABCB1']"
FATTY ACID OMEGA OXIDATION,2,"['CYP3A4', 'CYP2E1']"
DRUG INDUCTION OF BILE ACID PATHWAY,2,"['CYP3A4', 'ABCB1']"
FELBAMATE METABOLISM,2,"['CYP3A4', 'CYP2E1']"
CONSTITUTIVE ANDROSTANE RECEPTOR PATHWAY,2,"['CYP3A4', 'ABCB1']"
PREGNANE X RECEPTOR PATHWAY,2,"['CYP3A4', 'ABCB1']"
CANNABINOID RECEPTOR SIGNALING,2,"['CYP3A4', 'AHR']"
OXIDATION BY CYTOCHROME P450,2,"['CYP3A4', 'CYP2E1']"
TAMOXIFEN METABOLISM,2,"['CYP3A4', 'CYP2E1']"
PI METABOLISM,2,"['PIK3CA', 'PTEN']"
PHOSPHOLIPID METABOLISM,2,"['PIK3CA', 'PTEN']"
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE,2,"['PIK3CA', 'PTEN']"
REGULATION OF SIGNALING BY CBL,2,"['PIK3CA', 'CRK']"
MICROGLIA PATHOGEN PHAGOCYTOSIS PATHWAY,2,"['PIK3CA', 'ITGAM']"
METABOLIC REPROGRAMMING IN COLON CANCER,2,"['GPI', 'G6PD']"
HSF1-DEPENDENT TRANSACTIVATION,2,"['MTOR', 'CREBBP']"
SREBF AND MIR33 IN CHOLESTEROL AND LIPID HOMEOSTASIS,2,"['MTOR', 'PPARA']"
ATM SIGNALING NETWORK IN DEVELOPMENT AND DISEASE,2,"['MTOR', 'G6PD']"
CILIUM ASSEMBLY,2,"['RHO', 'BBS9']"
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE,2,"['RHO', 'BBS9']"
UBIQUITIN-DEPENDENT DEGRADATION OF CYCLIN D,2,"['CCND1', 'PSMB6']"
PPAR ALPHA PATHWAY,2,"['CCND1', 'PPARA']"
RORA ACTIVATES GENE EXPRESSION,2,"['PPARA', 'CREBBP']"
"BMAL1:CLOCK,NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION",2,"['PPARA', 'CREBBP']"
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP (SREBF),2,"['PPARA', 'CREBBP']"
ACTIVATION OF GENE EXPRESSION BY SREBF (SREBP),2,"['PPARA', 'CREBBP']"
GLUTATHIONE METABOLISM,2,"['G6PD', 'GSR']"
SULFATION BIOTRANSFORMATION REACTION,2,"['G6PD', 'GSR']"
IMATINIB AND CHRONIC MYELOID LEUKEMIA,2,"['ABCB1', 'KIT']"
INTEGRIN CELL SURFACE INTERACTIONS,2,"['ITGAM', 'CD44']"
INTERFERON GAMMA SIGNALING,2,"['CD44', 'IFNG']"
SIGNALING BY HEDGEHOG,2,"['GRK2', 'PSMB6']"
HEDGEHOG 'ON' STATE,2,"['GRK2', 'PSMB6']"
OXYGEN-DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA-INDUCIBLE FACTOR ALPHA,2,"['PSMB6', 'HIF1A']"
PROTEASOME DEGRADATION,2,"['PSMB6', 'IFNG']"
SIGNALING BY NOTCH1,2,"['CREBBP', 'HIF1A']"
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,2,"['CREBBP', 'HIF1A']"
CILIARY LANDSCAPE,2,"['CREBBP', 'BBS9']"
R-HSA-9646399,1,['CFTR']
R-HSA-9663891,1,['CFTR']
RHO GTPASES REGULATE CFTR TRAFFICKING,1,['CFTR']
CHAPERONE MEDIATED AUTOPHAGY,1,['CFTR']
MICROAUTOPHAGY,1,['CFTR']
ELASTIC FIBRE FORMATION,1,['TGFB1']
INFLUENZA LIFE CYCLE,1,['TGFB1']
INFLUENZA VIRUS INDUCED APOPTOSIS,1,['TGFB1']
MOLECULES ASSOCIATED WITH ELASTIC FIBRES,1,['TGFB1']
TGF-BETA RECEPTOR SIGNALING IN EMT (EPITHELIAL TO MESENCHYMAL TRANSITION),1,['TGFB1']
SYNDECAN INTERACTIONS,1,['TGFB1']
ECM PROTEOGLYCANS,1,['TGFB1']
LOSS OF FUNCTION OF TGFBR2 IN CANCER,1,['TGFB1']
TGFBR2 MSI FRAMESHIFT MUTANTS IN CANCER,1,['TGFB1']
TGFBR2 KINASE DOMAIN MUTANTS IN CANCER,1,['TGFB1']
TGFBR1 LBD MUTANTS IN CANCER,1,['TGFB1']
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS,1,['TNFRSF1A']
EV RELEASE FROM CARDIAC CELLS AND THEIR FUNCTIONAL EFFECTS,1,['TNF']
MHC CLASS II ANTIGEN PRESENTATION,1,['DCTN4']
COPI-INDEPENDENT GOLGI-TO-ER RETROGRADE TRAFFIC,1,['DCTN4']
INTRA-GOLGI AND RETROGRADE GOLGI-TO-ER TRAFFIC,1,['DCTN4']
GOLGI-TO-ER RETROGRADE TRANSPORT,1,['DCTN4']
SEROTONIN TRANSPORTER ACTIVITY,1,['IL1B']
ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN,1,['CA2']
ERYTHROCYTES TAKE UP OXYGEN AND RELEASE CARBON DIOXIDE,1,['CA2']
REVERSIBLE HYDRATION OF CARBON DIOXIDE,1,['CA2']
O2/CO2 EXCHANGE IN ERYTHROCYTES,1,['CA2']
"SYNTHESIS, SECRETION, AND INACTIVATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1)",1,['LEP']
"INCRETIN SYNTHESIS, SECRETION, AND INACTIVATION",1,['LEP']
LEPTIN AND ADIPONECTIN,1,['LEP']
INSULIN PROCESSING,1,['INS']
IRS ACTIVATION,1,['INS']
INSULIN RECEPTOR RECYCLING,1,['INS']
GLUCOSE HOMEOSTASIS,1,['INS']
MYD88 DEFICIENCY (TLR5),1,['TLR5']
IRAK4 DEFICIENCY (TLR5),1,['TLR5']
REGULATION BY C-FLIP,1,['FAS']
RIPK1-MEDIATED REGULATED NECROSIS,1,['FAS']
REGULATED NECROSIS,1,['FAS']
CASP8 ACTIVITY IS INHIBITED,1,['FAS']
REGULATION OF NECROPTOTIC CELL DEATH,1,['FAS']
DIMERIZATION OF PROCASPASE-8,1,['FAS']
FASL/ CD95L SIGNALING,1,['FAS']
ECTODERM DIFFERENTIATION,1,['CCL2']
INTERFERON ALPHA/BETA SIGNALING,1,['IFNA1']
REGULATION OF IFNA SIGNALING,1,['IFNA1']
OSTEOBLAST SIGNALING,1,['PTH']
DEFECTIVE SLC26A3 CAUSES CONGENITAL SECRETORY CHLORIDE DIARRHEA 1 (DIAR1),1,['SLC26A3']
COPII-MEDIATED VESICLE TRANSPORT,1,['SERPINA1']
CARGO CONCENTRATION IN THE ER,1,['SERPINA1']
DOWNREGULATION OF ERBB2:ERBB3 SIGNALING,1,['AKT1']
TRANSLOCATION OF SLC2A4 (GLUT4) TO THE PLASMA MEMBRANE,1,['AKT1']
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS,1,['AKT1']
METABOLISM OF NITRIC OXIDE: ENOS ACTIVATION AND REGULATION,1,['AKT1']
ENOS ACTIVATION,1,['AKT1']
AKT-MEDIATED INACTIVATION OF FOXO1A,1,['AKT1']
DEACTIVATION OF THE BETA-CATENIN TRANSACTIVATING COMPLEX,1,['AKT1']
G BETA:GAMMA SIGNALLING THROUGH PI3KGAMMA,1,['AKT1']
G-PROTEIN BETA:GAMMA SIGNALLING,1,['AKT1']
BUTYRATE RESPONSE FACTOR 1 (BRF1) BINDS AND DESTABILIZES MRNA,1,['AKT1']
KSRP (KHSRP) BINDS AND DESTABILIZES MRNA,1,['AKT1']
PTK6 REGULATES RTKS AND THEIR EFFECTORS AKT1 AND DOK1,1,['AKT1']
RAB GEFS EXCHANGE GTP FOR GDP ON RABS,1,['AKT1']
RUNX2 REGULATES GENES INVOLVED IN CELL MIGRATION,1,['AKT1']
RAB REGULATION OF TRAFFICKING,1,['AKT1']
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS,1,['AKT1']
WNT-BETA-CATENIN SIGNALING PATHWAY IN LEUKEMIA,1,['AKT1']
LIPID METABOLISM PATHWAY,1,['AKT1']
HFE EFFECT ON HEPCIDIN PRODUCTION,1,['HFE']
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS,1,['AQP2']
ION TRANSPORT BY P-TYPE ATPASES,1,['ATP12A']
INTERLEUKIN-2 SIGNALING,1,['IL2']
INTERLEUKIN-18 SIGNALING,1,['IL4']
R-HSA-9675143,1,['TTR']
RETINOID CYCLE DISEASE EVENTS,1,['TTR']
DISEASES ASSOCIATED WITH VISUAL TRANSDUCTION,1,['TTR']
KERATINIZATION,1,['PI3']
FORMATION OF THE CORNIFIED ENVELOPE,1,['PI3']
ALTERNATIVE COMPLEMENT ACTIVATION,1,['C3']
ACTIVATION OF C3 AND C5,1,['C3']
COMPLEMENT ACTIVATION,1,['C3']
CREATION OF C4 AND C2 ACTIVATORS,1,['CRP']
CLASSICAL ANTIBODY-MEDIATED COMPLEMENT ACTIVATION,1,['CRP']
UPTAKE AND ACTIONS OF BACTERIAL TOXINS,1,['GUCY2C']
DIGESTION,1,['GUCY2C']
INTESTINAL INFECTIOUS DISEASES,1,['GUCY2C']
DIGESTION AND ABSORPTION,1,['GUCY2C']
CATION-COUPLED CHLORIDE COTRANSPORTERS,1,['SLC12A2']
MIR-TARGETED GENES IN SQUAMOUS CELL - TARBASE,1,['SLC12A2']
CA2+ ACTIVATED K+ CHANNELS,1,['KCNN4']
RHO GTPASE CYCLE,1,['FAM13A']
DEFECTIVE SLC26A4 CAUSES PENDRED SYNDROME (PDS),1,['SLC26A4']
R-HSA-9609646,1,['EGFR']
R-HSA-9609690,1,['EGFR']
EGFR TRANSACTIVATION BY GASTRIN,1,['EGFR']
MECP2 REGULATES TRANSCRIPTION FACTORS,1,['PPARG']
TRANSCRIPTIONAL CASCADE REGULATING ADIPOGENESIS,1,['PPARG']
RECYCLING OF BILE ACIDS AND SALTS,1,['ALB']
METABOLISM OF PORPHYRINS,1,['ALB']
HEME BIOSYNTHESIS,1,['ALB']
HEME DEGRADATION,1,['ALB']
BILE ACID AND BILE SALT METABOLISM,1,['ALB']
"TRANSPORT OF VITAMINS, NUCLEOSIDES, AND RELATED MOLECULES",1,['ALB']
TRANSPORT OF ORGANIC ANIONS,1,['ALB']
HDL REMODELING,1,['ALB']
NOD1/2 SIGNALING PATHWAY,1,['NOD2']
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION,1,['NOD2']
PARKIN-UBIQUITIN PROTEASOMAL SYSTEM PATHWAY,1,['HSPA4']
ATP SENSITIVE POTASSIUM CHANNELS,1,['ABCC8']
INWARDLY RECTIFYING K+ CHANNELS,1,['ABCC8']
DEFECTIVE ABCC8 CAN CAUSE HYPOGLYCEMIAS AND HYPERGLYCEMIAS,1,['ABCC8']
R-HSA-9651496,1,['F2']
R-HSA-9657688,1,['F2']
R-HSA-9662001,1,['F2']
R-HSA-9671793,1,['F2']
R-HSA-9672391,1,['F2']
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION,1,['F2']
GAMMA-CARBOXYLATION OF PROTEIN PRECURSORS,1,['F2']
TRANSPORT OF GAMMA-CARBOXYLATED PROTEIN PRECURSORS FROM THE ENDOPLASMIC RETICULUM TO THE GOLGI APPARATUS,1,['F2']
REMOVAL OF AMINOTERMINAL PROPEPTIDES FROM GAMMA-CARBOXYLATED PROTEINS,1,['F2']
"GAMMA-CARBOXYLATION, TRANSPORT, AND AMINO-TERMINAL CLEAVAGE OF PROTEINS",1,['F2']
"GAMMA CARBOXYLATION, HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION",1,['F2']
BLOOD CLOTTING CASCADE,1,['F2']
DENGUE-2 INTERACTIONS WITH BLOOD CLOTTING CASCADE,1,['F2']
"COBALAMIN (CBL, VITAMIN B12) TRANSPORT AND METABOLISM",1,['PRSS1']
P2Y RECEPTORS,1,['P2RY2']
NUCLEOTIDE-LIKE (PURINERGIC) RECEPTORS,1,['P2RY2']
SURFACTANT METABOLISM,1,['P2RY2']
NUCLEOTIDE GPCRS,1,['P2RY2']
R-HSA-9636249,1,['NOS2']
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE,1,['NOS2']
EFFECTS OF NITRIC OXIDE,1,['NOS2']
SIGNALING BY NODAL,1,['SMAD3']
SIGNALING BY ACTIVIN,1,['SMAD3']
TRANSCRIPTIONAL ACTIVITY OF SMAD2/SMAD3:SMAD4 HETEROTRIMER,1,['SMAD3']
DOWNREGULATION OF SMAD2/3:SMAD4 TRANSCRIPTIONAL ACTIVITY,1,['SMAD3']
SMAD2/SMAD3:SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION,1,['SMAD3']
LOSS OF FUNCTION OF SMAD4 IN CANCER,1,['SMAD3']
SMAD4 MH2 DOMAIN MUTANTS IN CANCER,1,['SMAD3']
SMAD2/3 MH2 DOMAIN MUTANTS IN CANCER,1,['SMAD3']
RUNX3 REGULATES BCL2L11 (BIM) TRANSCRIPTION,1,['SMAD3']
METALLOPROTEASE DUBS,1,['NLRP3']
VEGF LIGAND-RECEPTOR INTERACTIONS,1,['VEGFA']
VEGF BINDS TO VEGFR LEADING TO RECEPTOR DIMERIZATION,1,['VEGFA']
VEGFR2 MEDIATED CELL PROLIFERATION,1,['VEGFA']
REGULATION OF HYPOXIA-INDUCIBLE FACTOR (HIF) BY OXYGEN,1,['VEGFA']
NOTCH1 REGULATION OF HUMAN ENDOTHELIAL CELL CALCIFICATION,1,['VEGFA']
AMPLIFICATION AND EXPANSION OF ONCOGENIC PATHWAYS AS METASTATIC TRAITS,1,['VEGFA']
ROBO4 AND VEGF SIGNALING PATHWAYS CROSSTALK,1,['VEGFA']
ACTIVATION OF NOXA AND TRANSLOCATION TO MITOCHONDRIA,1,['TP53']
ACTIVATION OF PUMA AND TRANSLOCATION TO MITOCHONDRIA,1,['TP53']
FORMATION OF SENESCENCE-ASSOCIATED HETEROCHROMATIN FOCI (SAHF),1,['TP53']
SUMOYLATION OF TRANSCRIPTION FACTORS,1,['TP53']
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53-DEPENDENT APOPTOSIS REMAIN UNCERTAIN,1,['TP53']
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES,1,['TP53']
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN,1,['TP53']
REGULATION OF TP53 EXPRESSION,1,['TP53']
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION,1,['TP53']
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION,1,['TP53']
PI5P REGULATES TP53 ACETYLATION,1,['TP53']
G2/M DNA DAMAGE CHECKPOINT,1,['TP53']
FLUOROPYRIMIDINE ACTIVITY,1,['TP53']
METASTATIC BRAIN TUMOR,1,['TP53']
ULTRACONSERVED REGION 339 MODULATION OF TUMOR SUPPRESSOR MICRORNAS IN CANCER,1,['TP53']
THE EFFECT OF PROGERIN ON THE INVOLVED GENES IN HUTCHINSON-GILFORD PROGERIA SYNDROME,1,['TP53']
R-HSA-9652817,1,['MAPK1']
PHOSPHO-PLA2 PATHWAY,1,['MAPK1']
RECYCLING PATHWAY OF L1,1,['MAPK1']
ESTROGEN-STIMULATED SIGNALING THROUGH PRKCZ,1,['MAPK1']
ENDOTHELIN PATHWAYS,1,['MAPK1']
MAPK AND NFKB SIGNALLING PATHWAYS INHIBITED BY YERSINIA YOPJ,1,['MAPK1']
METABOLISM OF AMINE-DERIVED HORMONES,1,['TH']
CATECHOLAMINE BIOSYNTHESIS,1,['TH']
NICOTINE ACTIVITY ON DOPAMINERGIC NEURONS,1,['TH']
BIOGENIC AMINE SYNTHESIS,1,['TH']
ALPHA-DEFENSINS,1,['CD4']
HIV LIFE CYCLE,1,['CD4']
EARLY PHASE OF HIV LIFE CYCLE,1,['CD4']
NEF-MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS,1,['CD4']
THE ROLE OF NEF IN HIV-1 REPLICATION AND DISEASE PATHOGENESIS,1,['CD4']
NEF MEDIATED CD4 DOWN-REGULATION,1,['CD4']
BINDING AND ENTRY OF HIV VIRION,1,['CD4']
PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS,1,['CD4']
TRANSLOCATION OF ZAP-70 TO IMMUNOLOGICAL SYNAPSE,1,['CD4']
GENERATION OF SECOND MESSENGER MOLECULES,1,['CD4']
PD-1 SIGNALING,1,['CD4']
R-HSA-9031628,1,['FOS']
SEROTONIN AND ANXIETY-RELATED EVENTS,1,['FOS']
ANDROGEN BIOSYNTHESIS,1,['POMC']
GLUCOCORTICOID BIOSYNTHESIS,1,['POMC']
METABOLISM OF STEROID HORMONES,1,['POMC']
G-PROTEIN ACTIVATION,1,['POMC']
PEPTIDE HORMONE BIOSYNTHESIS,1,['POMC']
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES,1,['POMC']
DEFECTIVE ACTH CAUSES OBESITY AND PRO-OPIOMELANOCORTININ DEFICIENCY (POMCD),1,['POMC']
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES,1,['MMP9']
RHO GTPASES ACTIVATE PKNS,1,['AR']
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR (ANDROGEN RECEPTOR) REGULATED GENES KLK2 AND KLK3,1,['AR']
R-HSA-9664420,1,['MAPK8']
R-HSA-9673324,1,['MAPK8']
ACTIVATION OF BIM AND TRANSLOCATION TO MITOCHONDRIA ,1,['MAPK8']
ACTIVATION OF BMF AND TRANSLOCATION TO MITOCHONDRIA,1,['MAPK8']
NRAGE SIGNALS DEATH THROUGH JNK,1,['MAPK8']
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS,1,['MAPK8']
NETRIN-1 SIGNALING,1,['MAPK8']
DSCAM INTERACTIONS,1,['MAPK8']
INTERLEUKIN-38 SIGNALING,1,['MAPK8']
OSTEOCLAST SIGNALING,1,['MAPK8']
WNT SIGNALING IN KIDNEY DISEASE,1,['MAPK8']
TFAP2 (AP-2) FAMILY REGULATES TRANSCRIPTION OF CELL CYCLE FACTORS,1,['CDKN1A']
INTEGRATED CANCER PATHWAY,1,['CDKN1A']
DNA DAMAGE-TELOMERE STRESS INDUCED SENESCENCE,1,['CDKN1A']
MIR-517 RELATIONSHIP WITH ARCN1 AND USP1,1,['CDKN1A']
GENOTOXICITY PATHWAY,1,['CDKN1A']
RUNX1 REGULATES ESTROGEN RECEPTOR MEDIATED TRANSCRIPTION,1,['ESR1']
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN WNT SIGNALING,1,['ESR1']
ZBP1(DAI) MEDIATED INDUCTION OF TYPE I IFNS,1,['RELA']
RIP-MEDIATED NFKB ACTIVATION VIA ZBP1,1,['RELA']
P75NTR SIGNALS VIA NF-KB,1,['RELA']
REGULATED PROTEOLYSIS OF P75NTR,1,['RELA']
NF-KB IS ACTIVATED AND SIGNALS SURVIVAL,1,['RELA']
DEX/H-BOX HELICASES ACTIVATE TYPE I IFN AND INFLAMMATORY CYTOKINES PRODUCTION ,1,['RELA']
PKMTS METHYLATE HISTONE LYSINES,1,['RELA']
SUMOYLATION OF IMMUNE RESPONSE PROTEINS,1,['RELA']
IKBA VARIANT LEADS TO EDA-ID,1,['RELA']
TRAF6 MEDIATED NF-KB ACTIVATION,1,['RELA']
SUPRESSION OF HMGB1 MEDIATED INFLAMMATION BY THBD,1,['RELA']
NICOTINATE METABOLISM,1,['PTGS2']
NICOTINAMIDE SALVAGING,1,['PTGS2']
ARACHIDONIC ACID METABOLISM,1,['PTGS2']
SYNTHESIS OF 15-EICOSATETRAENOIC ACID DERIVATIVES,1,['PTGS2']
SYNTHESIS OF PROSTAGLANDINS (PG) AND THROMBOXANES (TX),1,['PTGS2']
FATTY ACID METABOLISM,1,['PTGS2']
BIOSYNTHESIS OF EPA-DERIVED SPMS,1,['PTGS2']
BIOSYNTHESIS OF DPA-DERIVED SPMS,1,['PTGS2']
BIOSYNTHESIS OF DPAN-3 SPMS,1,['PTGS2']
BIOSYNTHESIS OF ELECTROPHILIC -3 PUFA OXO-DERIVATIVES,1,['PTGS2']
EICOSANOID SYNTHESIS,1,['PTGS2']
GASTRIC ULCER FORMATION,1,['PTGS2']
RELEASE OF APOPTOTIC FACTORS FROM THE MITOCHONDRIA,1,['BAX']
"ACTIVATION, TRANSLOCATION AND OLIGOMERIZATION OF BAX",1,['BAX']
NTRK3 AS A DEPENDENCE RECEPTOR,1,['BAX']
MITOCHONDRIAL FATTY ACID SYNTHESIS AND RESPIRATION,1,['BAX']
SIGNALLING TO STAT3,1,['STAT3']
"POU5F1 (OCT4), SOX2, NANOG ACTIVATE GENES RELATED TO PROLIFERATION",1,['STAT3']
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS,1,['STAT3']
PTK6 ACTIVATES STAT3,1,['STAT3']
INTERLEUKIN-20 FAMILY SIGNALING,1,['STAT3']
MET ACTIVATES STAT3,1,['STAT3']
INTERLEUKIN-15 SIGNALING,1,['STAT3']
INTERLEUKIN-35 SIGNALLING,1,['STAT3']
INTERLEUKIN-9 SIGNALING,1,['STAT3']
INTERLEUKIN-23 SIGNALING,1,['STAT3']
INTERLEUKIN-27 SIGNALING,1,['STAT3']
INTERLEUKIN-21 SIGNALING,1,['STAT3']
CELL DIFFERENTIATION - INDEX EXPANDED,1,['STAT3']
CELL DIFFERENTIATION - INDEX,1,['STAT3']
DEVELOPMENT OF PULMONARY DENDRITIC CELLS AND MACROPHAGE SUBSETS,1,['STAT3']
HDAC6 INTERACTIONS,1,['STAT3']
SEROTONIN RECEPTOR 2 AND STAT3 SIGNALING,1,['STAT3']
R-HSA-9664323,1,['IL10']
AFLATOXIN ACTIVATION AND DETOXIFICATION,1,['CYP3A4']
IRINOTECAN PATHWAY,1,['CYP3A4']
LIDOCAINE METABOLISM,1,['CYP3A4']
COCAINE METABOLISM,1,['CYP3A4']
LIVER X RECEPTOR PATHWAY,1,['CYP3A4']
FARNESOID X RECEPTOR PATHWAY,1,['CYP3A4']
BENZO(A)PYRENE METABOLISM,1,['CYP3A4']
ESTROGEN METABOLISM,1,['CYP3A4']
AFLATOXIN B1 METABOLISM,1,['CYP3A4']
MAPK6-MAPK4 SIGNALING,1,['MMP2']
PI3K CASCADE,1,['PIK3CA']
IRS-MEDIATED SIGNALLING,1,['PIK3CA']
GPVI-MEDIATED ACTIVATION CASCADE,1,['PIK3CA']
PI3K EVENTS IN ERBB4 SIGNALING,1,['PIK3CA']
CELL-CELL COMMUNICATION,1,['PIK3CA']
PI3K/AKT ACTIVATION,1,['PIK3CA']
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS,1,['PIK3CA']
TIE2 SIGNALING,1,['PIK3CA']
DAP12 INTERACTIONS,1,['PIK3CA']
SIGNALING BY TYPE 1 INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF1R),1,['PIK3CA']
DAP12 SIGNALING,1,['PIK3CA']
IGF1R SIGNALING CASCADE,1,['PIK3CA']
IRS-RELATED EVENTS TRIGGERED BY IGF1R,1,['PIK3CA']
ROLE OF LAT2/NTAL/LAB ON CALCIUM MOBILIZATION,1,['PIK3CA']
NEPHRIN FAMILY INTERACTIONS,1,['PIK3CA']
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1,1,['PIK3CA']
PI-3K CASCADE:FGFR1,1,['PIK3CA']
PI-3K CASCADE:FGFR2,1,['PIK3CA']
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2,1,['PIK3CA']
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3,1,['PIK3CA']
PI-3K CASCADE:FGFR3,1,['PIK3CA']
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4,1,['PIK3CA']
PI-3K CASCADE:FGFR4,1,['PIK3CA']
SIGNALING BY FGFR2 IN DISEASE,1,['PIK3CA']
SIGNALING BY FGFR4 IN DISEASE,1,['PIK3CA']
SIGNALING BY FGFR3 IN DISEASE,1,['PIK3CA']
MET ACTIVATES PI3K/AKT SIGNALING,1,['PIK3CA']
SIGNALING BY FGFR3 FUSIONS IN CANCER,1,['PIK3CA']
SIGNALING BY FGFR3 POINT MUTANTS IN CANCER,1,['PIK3CA']
RET SIGNALING,1,['PIK3CA']
SIGNALING BY NTRK2 (TRKB),1,['PIK3CA']
SIGNALING BY ERYTHROPOIETIN,1,['PIK3CA']
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE-3-KINASE (PI3K),1,['PIK3CA']
ACTIVATED NTRK2 SIGNALS THROUGH PI3K,1,['PIK3CA']
ACTIVATED NTRK3 SIGNALS THROUGH PI3K,1,['PIK3CA']
G13 SIGNALING PATHWAY,1,['PIK3CA']
ISG15 ANTIVIRAL MECHANISM,1,['MAPK3']
ANTIVIRAL MECHANISM BY IFN-STIMULATED GENES,1,['MAPK3']
RNA POLYMERASE I PROMOTER OPENING,1,['MAPK3']
RNA POLYMERASE I PROMOTER CLEARANCE,1,['MAPK3']
RNA POLYMERASE I TRANSCRIPTION,1,['MAPK3']
GLYCOLYSIS,1,['GPI']
GLUCONEOGENESIS,1,['GPI']
GLUCOSE METABOLISM,1,['GPI']
GLYCOLYSIS AND GLUCONEOGENESIS,1,['GPI']
TRP CHANNELS,1,['MCOLN1']
IRON METABOLISM IN PLACENTA,1,['MCOLN1']
"TRANSPORT OF BILE SALTS AND ORGANIC ACIDS, METAL IONS AND AMINE COMPOUNDS",1,['CP']
METAL ION SLC TRANSPORTERS,1,['CP']
DEFECTIVE SLC40A1 CAUSES HEMOCHROMATOSIS 4 (HFE4) (MACROPHAGES),1,['CP']
DEFECTIVE CP CAUSES ACERULOPLASMINEMIA (ACERULOP),1,['CP']
ACTIVATION OF CASPASES THROUGH APOPTOSOME-MEDIATED CLEAVAGE,1,['CASP3']
SMAC (DIABLO) BINDS TO IAPS ,1,['CASP3']
SMAC(DIABLO)-MEDIATED DISSOCIATION OF IAP:CASPASE COMPLEXES ,1,['CASP3']
"SMAC, XIAP-REGULATED APOPTOTIC RESPONSE",1,['CASP3']
APOPTOSIS INDUCED DNA FRAGMENTATION,1,['CASP3']
SIGNALING BY HIPPO,1,['CASP3']
NADE MODULATES DEATH SIGNALLING,1,['CASP3']
STIMULATION OF THE CELL DEATH RESPONSE BY PAK-2P34,1,['CASP3']
APOPTOTIC CLEAVAGE OF CELL ADHESION  PROTEINS,1,['CASP3']
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND,1,['CASP3']
MTHFR DEFICIENCY,1,['CASP3']
THE NLRP1 INFLAMMASOME,1,['BCL2']
INFLUENZA A VIRUS INFECTION,1,['BCL2']
NANOPARTICLE TRIGGERED AUTOPHAGIC CELL DEATH,1,['BCL2']
R-HSA-9639288,1,['MTOR']
MTORC1-MEDIATED SIGNALLING,1,['MTOR']
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1-AMPK,1,['MTOR']
ACTIVATION OF THE PHOTOTRANSDUCTION CASCADE,1,['RHO']
THE PHOTOTRANSDUCTION CASCADE,1,['RHO']
"INACTIVATION, RECOVERY AND REGULATION OF THE PHOTOTRANSDUCTION CASCADE",1,['RHO']
OPSINS,1,['RHO']
VXPX CARGO-TARGETING TO CILIUM,1,['RHO']
RMTS METHYLATE HISTONE ARGININES,1,['CCND1']
PTK6 REGULATES CELL CYCLE,1,['CCND1']
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY,1,['CCND1']
RUNX3 REGULATES WNT SIGNALING,1,['CCND1']
H19 ACTION RB-E2F1 SIGNALING AND CDK-BETA-CATENIN ACTIVITY,1,['CCND1']
LNCRNA INVOLVEMENT IN CANONICAL WNT SIGNALING AND COLORECTAL CANCER,1,['CCND1']
NCRNAS INVOLVED IN WNT SIGNALING IN HEPATOCELLULAR CARCINOMA,1,['CCND1']
LIPID STORAGE AND PERILIPINS IN SKELETAL MUSCLE,1,['PPARA']
"BMAL1-CLOCK,NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION",1,['PPARA']
PENTOSE PHOSPHATE PATHWAY,1,['G6PD']
PENTOSE PHOSPHATE METABOLISM,1,['G6PD']
FIG-MET-1-LAST-SOLUTION,1,['G6PD']
ABACAVIR TRANSMEMBRANE TRANSPORT,1,['ABCB1']
ABACAVIR TRANSPORT AND METABOLISM,1,['ABCB1']
R-HSA-9635644,1,['HGS']
R-HSA-9636383,1,['HGS']
TRANS-GOLGI NETWORK VESICLE BUDDING,1,['HGS']
LYSOSOME VESICLE BIOGENESIS,1,['HGS']
NEGATIVE REGULATION OF MET ACTIVITY,1,['HGS']
INLB-MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL,1,['HGS']
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS,1,['HGS']
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT (ESCRT),1,['HGS']
MECP2 REGULATES TRANSCRIPTION OF NEURONAL LIGANDS,1,['SST']
BMP2-WNT4-FOXO1 PATHWAY IN HUMAN PRIMARY ENDOMETRIAL STROMAL CELL DIFFERENTIATION,1,['SST']
HORMONAL CONTROL OF PUBERTAL GROWTH SPURT,1,['SST']
TNF RECEPTOR SUPERFAMILY (TNFSF) MEMBERS MEDIATING NON-CANONICAL NF-KB PATHWAY,1,['CD40']
ARYL HYDROCARBON RECEPTOR SIGNALLING,1,['AHR']
METABOLISM OF NUCLEOTIDES,1,['GSR']
SELENOAMINO ACID METABOLISM,1,['GSR']
METABOLISM OF INGESTED H2SEO4 AND H2SEO3 INTO H2SE,1,['GSR']
INTERCONVERSION OF NUCLEOTIDE DI- AND TRIPHOSPHATES,1,['GSR']
GLYCOSAMINOGLYCAN METABOLISM,1,['CD44']
HYALURONAN METABOLISM,1,['CD44']
HYALURONAN UPTAKE AND DEGRADATION,1,['CD44']
VITAMIN D (CALCIFEROL) METABOLISM,1,['GC']
CELL-TYPE DEPENDENT SELECTIVITY OF CCK2R SIGNALING,1,['CCK']
CALMODULIN INDUCED EVENTS,1,['GRK2']
CAM PATHWAY,1,['GRK2']
DAG AND IP3 SIGNALING,1,['GRK2']
ACTIVATION OF SMO,1,['GRK2']
CROSS-PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS (ENDOSOMES),1,['PSMB6']
REGULATION OF APOPTOSIS,1,['PSMB6']
AUTODEGRADATION OF CDH1 BY CDH1:APC/C,1,['PSMB6']
SCF-BETA-TRCP MEDIATED DEGRADATION OF EMI1,1,['PSMB6']
APC/C-MEDIATED DEGRADATION OF CELL CYCLE PROTEINS,1,['PSMB6']
APC/C:CDC20 MEDIATED DEGRADATION OF SECURIN,1,['PSMB6']
APC/C:CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC/C:CDH1 TARGETED PROTEINS IN LATE MITOSIS/EARLY G1,1,['PSMB6']
CDC20:PHOSPHO-APC/C MEDIATED DEGRADATION OF CYCLIN A,1,['PSMB6']
REGULATION OF APC/C ACTIVATORS BETWEEN G1/S AND EARLY ANAPHASE,1,['PSMB6']
APC/C:CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS,1,['PSMB6']
ACTIVATION OF APC/C AND APC/C:CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS,1,['PSMB6']
APC:CDC20 MEDIATED DEGRADATION OF CELL CYCLE PROTEINS PRIOR TO SATISFATION OF THE CELL CYCLE CHECKPOINT,1,['PSMB6']
VIF-MEDIATED DEGRADATION OF APOBEC3G,1,['PSMB6']
DEGRADATION OF BETA-CATENIN BY THE DESTRUCTION COMPLEX,1,['PSMB6']
REGULATION OF ACTIVATED PAK-2P34 BY PROTEASOME MEDIATED DEGRADATION,1,['PSMB6']
SEPARATION OF SISTER CHROMATIDS,1,['PSMB6']
MITOTIC METAPHASE AND ANAPHASE,1,['PSMB6']
REGULATION OF ORNITHINE DECARBOXYLASE (ODC),1,['PSMB6']
METABOLISM OF POLYAMINES,1,['PSMB6']
SIGNALING BY ROBO RECEPTORS,1,['PSMB6']
BETA-CATENIN INDEPENDENT WNT SIGNALING,1,['PSMB6']
PCP/CE PATHWAY,1,['PSMB6']
AUF1 (HNRNP D0) BINDS AND DESTABILIZES MRNA,1,['PSMB6']
REGULATION OF MITOTIC CELL CYCLE,1,['PSMB6']
ASYMMETRIC LOCALIZATION OF PCP PROTEINS,1,['PSMB6']
DEGRADATION OF AXIN,1,['PSMB6']
DEGRADATION OF DVL,1,['PSMB6']
HEDGEHOG LIGAND BIOGENESIS,1,['PSMB6']
HH MUTANTS THAT DON'T UNDERGO AUTOCATALYTIC PROCESSING ARE DEGRADED BY ERAD,1,['PSMB6']
HH MUTANTS ABROGATE LIGAND SECRETION,1,['PSMB6']
DEGRADATION OF GLI1 BY THE PROTEASOME,1,['PSMB6']
DEGRADATION OF GLI2 BY THE PROTEASOME,1,['PSMB6']
GLI3 IS PROCESSED TO GLI3R BY THE PROTEASOME,1,['PSMB6']
HEDGEHOG 'OFF' STATE,1,['PSMB6']
REGULATION OF RAS BY GAPS,1,['PSMB6']
NIK-->NONCANONICAL NF-KB SIGNALING,1,['PSMB6']
MAPK6/MAPK4 SIGNALING,1,['PSMB6']
CDT1 ASSOCIATION WITH THE CDC6:ORC:ORIGIN COMPLEX,1,['PSMB6']
ASSEMBLY OF THE PRE-REPLICATIVE COMPLEX,1,['PSMB6']
MITOTIC ANAPHASE,1,['PSMB6']
ORC1 REMOVAL FROM CHROMATIN,1,['PSMB6']
DNA REPLICATION PRE-INITIATION,1,['PSMB6']
CDK-MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6,1,['PSMB6']
SWITCHING OF ORIGINS TO A POST-REPLICATIVE STATE,1,['PSMB6']
SYNTHESIS OF DNA,1,['PSMB6']
DNA REPLICATION,1,['PSMB6']
UBIQUITIN MEDIATED DEGRADATION OF PHOSPHORYLATED CDC25A,1,['PSMB6']
P53-INDEPENDENT DNA DAMAGE RESPONSE,1,['PSMB6']
P53-INDEPENDENT G1/S DNA DAMAGE CHECKPOINT,1,['PSMB6']
FBXL7 DOWN-REGULATES AURKA DURING MITOTIC ENTRY AND IN EARLY MITOSIS,1,['PSMB6']
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS,1,['PSMB6']
REGULATION OF EXPRESSION OF SLITS AND ROBOS,1,['PSMB6']
ANTIGEN PROCESSING: UBIQUITINATION & PROTEASOME DEGRADATION,1,['PSMB6']
FORMATION OF THE BETA-CATENIN:TCF TRANSACTIVATING COMPLEX,1,['CREBBP']
REGULATION OF GENE EXPRESSION IN LATE STAGE (BRANCHING MORPHOGENESIS) PANCREATIC BUD PRECURSOR CELLS,1,['CREBBP']
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER,1,['CREBBP']
SIGNALING BY NOTCH1 IN CANCER,1,['CREBBP']
CONSTITUTIVE SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS,1,['CREBBP']
SIGNALING BY NOTCH1 HD+PEST DOMAIN MUTANTS IN CANCER,1,['CREBBP']
CONSTITUTIVE SIGNALING BY NOTCH1 HD+PEST DOMAIN MUTANTS,1,['CREBBP']
LRR FLII-INTERACTING PROTEIN 1 (LRRFIP1) ACTIVATES TYPE I IFN PRODUCTION,1,['CREBBP']
HATS ACETYLATE HISTONES,1,['CREBBP']
ATTENUATION PHASE,1,['CREBBP']
NOTCH-HLH TRANSCRIPTION PATHWAY,1,['CREBBP']
SUMOYLATION OF TRANSCRIPTION COFACTORS,1,['CREBBP']
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS,1,['CREBBP']
ACTIVATION OF HOX GENES DURING DIFFERENTIATION,1,['CREBBP']
ACTIVATION OF THE TFAP2 (AP-2) FAMILY OF TRANSCRIPTION FACTORS,1,['CREBBP']
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF MYELOID CELLS,1,['CREBBP']
RUNX3 REGULATES NOTCH SIGNALING,1,['CREBBP']
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,1,['CREBBP']
TRAF3-DEPENDENT IRF ACTIVATION PATHWAY,1,['CREBBP']
FOXO-MEDIATED TRANSCRIPTION OF CELL DEATH GENES,1,['CREBBP']
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION,1,['CREBBP']
NOTCH SIGNALING,1,['CREBBP']
SIALIC ACID METABOLISM,1,['SLC17A5']
ORGANIC ANION TRANSPORTERS,1,['SLC17A5']
"BIOSYNTHESIS OF THE N-GLYCAN PRECURSOR (DOLICHOL LIPID-LINKED OLIGOSACCHARIDE, LLO) AND TRANSFER TO A NASCENT PROTEIN",1,['SLC17A5']
SYNTHESIS OF SUBSTRATES IN N-GLYCAN BIOSYTHESIS,1,['SLC17A5']
DEFECTIVE SLC17A5 CAUSES SALLA DISEASE (SD) AND ISSD,1,['SLC17A5']
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES,1,['PPIB']
R-HSA-9645723,1,['SOD2']
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER'S DISEASE MODELS,1,['SOD2']
NEURODEGENERATIVE DISEASES,1,['SOD2']
"DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER,S DISEASE MODELS",1,['SOD2']
REGULATION OF IFNG SIGNALING,1,['IFNG']
BBSOME-MEDIATED CARGO-TARGETING TO CILIUM,1,['BBS9']
SCAVENGING BY CLASS B RECEPTORS,1,['APOB']
SCAVENGING BY CLASS A RECEPTORS,1,['APOB']
SCAVENGING BY CLASS F RECEPTORS,1,['APOB']
SCAVENGING BY CLASS H RECEPTORS,1,['APOB']
PLATELET SENSITIZATION BY LDL,1,['APOB']
VLDL ASSEMBLY,1,['APOB']
CHYLOMICRON ASSEMBLY,1,['APOB']
PLASMA LIPOPROTEIN ASSEMBLY,1,['APOB']
CHYLOMICRON REMODELING,1,['APOB']
CHYLOMICRON CLEARANCE,1,['APOB']
LDL CLEARANCE,1,['APOB']
LDL REMODELING,1,['APOB']
PLASMA LIPOPROTEIN CLEARANCE,1,['APOB']
VLDL CLEARANCE,1,['APOB']
STATIN PATHWAY,1,['APOB']
ARMS-MEDIATED ACTIVATION,1,['CRK']
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS,1,['CRK']
"PTK6 REGULATES RHO GTPASES, RAS GTPASE AND MAP KINASES",1,['CRK']
MET ACTIVATES RAP1 AND RAC1,1,['CRK']
MET RECEPTOR RECYCLING,1,['CRK']
MET PROMOTES CELL MOTILITY,1,['CRK']
RETT SYNDROME CAUSING GENES,1,['CRK']
R-HSA-9669914,1,['KIT']
R-HSA-9669917,1,['KIT']
R-HSA-9669921,1,['KIT']
R-HSA-9669924,1,['KIT']
R-HSA-9669926,1,['KIT']
R-HSA-9669929,1,['KIT']
R-HSA-9669933,1,['KIT']
R-HSA-9669934,1,['KIT']
R-HSA-9669935,1,['KIT']
R-HSA-9669936,1,['KIT']
R-HSA-9669937,1,['KIT']
R-HSA-9680187,1,['KIT']
REGULATION OF KIT SIGNALING,1,['KIT']
CYP2E1 REACTIONS,1,['CYP2E1']
FOLATE-ALCOHOL AND CANCER PATHWAY HYPOTHESES,1,['CYP2E1']
GUT-LIVER INDOLE METABOLISM,1,['CYP2E1']
METABOLISM OF DICHLOROETHYLENE BY CYP450,1,['CYP2E1']
ETHANOL EFFECTS ON HISTONE MODIFICATIONS,1,['CYP2E1']
ACRYLAMIDE BIOTRANSFORMATION AND EXPOSURE BIOMARKERS,1,['CYP2E1']
THYROXINE (THYROID HORMONE) PRODUCTION,1,['TG']
INOSITOL PHOSPHATE METABOLISM,1,['PTEN']
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL,1,['PTEN']
PTEN LOSS OF FUNCTION IN CANCER,1,['PTEN']
REGULATION OF PTEN MRNA TRANSLATION,1,['PTEN']
REGULATION OF PTEN LOCALIZATION,1,['PTEN']
